{"content":"<li class=\"n-box-item date-title\" data-end=\"1551157199\" data-start=\"1551070800\" data-txt=\"Monday, December 23, 2019\">Monday, February 25, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3436903\" data-ts=\"1551141647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DHR\" target=\"_blank\">DHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436903-danaher-launches-2_7b-equity-offering-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Danaher launches $2.7B equity offering; shares down 1% after hours</a></h4><ul><li>Aimed at funding part of its <a href=\"https://seekingalpha.com/news/3436455-ge-sell-biopharma-unit-danaher-21_4b\" target=\"_blank\">acquisition </a>of GE's BioPharma unit, Danaher (NYSE:<a href='https://seekingalpha.com/symbol/DHR' title='Danaher Corporation'>DHR</a>) <a href=\"https://seekingalpha.com/pr/17423512-danaher-announces-offerings-common-stock-mandatory-convertible-preferred-stock\" target=\"_blank\">launches </a>a public offering of $1.35B of common stock and $1.35B of Series A Convertible Preferred Stock.</li><li>Prices, volumes and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">1%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436903\" data-linked=\"Danaher launches $2.7B equity offering; shares down 1% after hours\" data-tweet=\"$DHR - Danaher launches $2.7B equity offering; shares down 1% after hours https://seekingalpha.com/news/3436903-danaher-launches-2_7b-equity-offering-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436903-danaher-launches-2_7b-equity-offering-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436899\" data-ts=\"1551137970\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRC\" target=\"_blank\">RRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436899-range-resourcesplus-2-following-easy-beats-for-q4-earnings-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Range Resources +2% following easy beats for Q4 earnings, revenues</a></h4><ul><li>Range Resources (NYSE:<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a>) <font color=\"green\">+1.9%</font> after-hours as it easily beats Wall Street expectations for <a href=\"https://seekingalpha.com/news/3436883-range-resources-beats-0_17-beats-revenue\" target=\"_blank\">Q4 earnings</a> and revenues and providing production guidance.</li><li>Q4 average natural gas price, including the impact of basis hedging, was  $3.53/Mcf, or an $0.08/Mcf differential to Nymex, vs. the $0.35 differential during the prior-year quarter, which the company says was the result of increased pipeline connectivity and compressed  basis across the Appalachian and Midwest regions.</li><li>RRC forecasts FY 2019 production 2.325M-2.345M cfe/day, or 6% Y/Y growth at the midpoint, while seeing Q1 production averaging 2.225M cfe/day.</li><li>The company expects 2019 capital spending of ~$756M and projects cash flow to exceed spending for the year; also, asset sales will be pursued to further strengthen the balance sheet.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436899\" data-linked=\"Range Resources +2% following easy beats for Q4 earnings, revenues\" data-tweet=\"$RRC - Range Resources +2% following easy beats for Q4 earnings, revenues https://seekingalpha.com/news/3436899-range-resourcesplus-2-following-easy-beats-for-q4-earnings-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3436899-range-resourcesplus-2-following-easy-beats-for-q4-earnings-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>31&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436898\" data-ts=\"1551136817\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436898-teslaminus-4_3-sec-reportedly-seeks-contempt-charge-for-musk-updated\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla -4.3% as SEC reportedly seeks contempt charge for Musk (updated)</a></h4><ul>   <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) has taken a <font color=\"red\">4.3% dip</font> after hours amid Bloomberg reports that the SEC has asked a judge to hold CEO Elon Musk in contempt for violating their deal.</li>    <li>That's headlines-only news for right now, but the stock is moving.</li>    <li>The SEC cited an \"inaccurate\" Feb. 19 tweet about production as evidence.</li><li>On Feb. 19, Musk <a href=\"https://twitter.com/elonmusk/status/1098013283372589056\" target=\"_blank\">tweeted</a> \"Tesla made 0 cars in 2011, but will make around 500k in 2019,\" a <a href=\"https://twitter.com/elonmusk/status/1098080063801585664\" target=\"_blank\">few hours later adding</a> \"Meant to say annualized production rate at end of 2019 probably around 500k, ie 10k cars/week. Deliveries for year still estimated to be about 400k.\"</li>    <li><b>Updated:</b> With <a href=\"https://www.bloomberg.com/news/articles/2019-02-25/elon-musk-faces-u-s-contempt-claim-for-violating-sec-accord\" target=\"_blank\">Bloomberg details</a>. The tweet about producing 500,000 cars reportedly violates the settlement where Musk was required to seek preapproval from the company for posts that would be material to the company or investors.</li>    <li>\u201cHe once again published inaccurate and material information about Tesla to his over 24 million Twitter followers, including members of the press, and made this inaccurate information available to anyone with Internet access,\u201d the SEC said in court papers. Tesla's now <font color=\"red\">down 4.6%</font> after hours at 6:58 p.m.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436898\" data-linked=\"Tesla -4.3% as SEC reportedly seeks contempt charge for Musk (updated)\" data-tweet=\"$TSLA - Tesla -4.3% as SEC reportedly seeks contempt charge for Musk (updated) https://seekingalpha.com/news/3436898-teslaminus-4_3-sec-reportedly-seeks-contempt-charge-for-musk-updated?source=tweet\" data-url=\"https://seekingalpha.com/news/3436898-teslaminus-4_3-sec-reportedly-seeks-contempt-charge-for-musk-updated\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>624&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436897\" data-ts=\"1551136258\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FND\" target=\"_blank\">FND</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436897-floor-decorminus-2-amid-10m-share-secondary-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Floor &amp; Decor -2% amid 10M-share secondary offering</a></h4><ul>   <li>Floor &amp; Decor (NYSE:<a href='https://seekingalpha.com/symbol/FND' title='Floor & Decor Holdings, Inc.'>FND</a>) is <font color=\"red\">down 2%</font> after hours following the announcement of a <a href=\"https://seekingalpha.com/pr/17423471-floor-and-decor-holdings-inc-announces-secondary-offering-10000-000-shares-common-stock\" target=\"_blank\">secondary offering</a> of 10M shares by selling stockholders.</li>    <li>Those stockholders include Ares Management and Freeman Spogli Management along with officers and directors. The company's not selling any shares and won't see any proceeds.</li>    <li>Those shares are said to come at $37.75-$38.25, Bloomberg says, vs. today's closing price of $38.75.</li>    <li>Underwriters (J.P. Morgan and Goldman Sachs) will get a 30-day option to buy up to 1.5M more shares.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436897\" data-linked=\"Floor &amp; Decor -2% amid 10M-share secondary offering\" data-tweet=\"$FND - Floor &amp; Decor -2% amid 10M-share secondary offering https://seekingalpha.com/news/3436897-floor-decorminus-2-amid-10m-share-secondary-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3436897-floor-decorminus-2-amid-10m-share-secondary-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436892\" data-ts=\"1551135290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APTS\" target=\"_blank\">APTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436892-preferred-apartment-q4-multifamily-store-noiminus-5_1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Preferred Apartment Q4 multifamily same-store NOI -5.1%</a></h4><ul><li>Preferred Apartment Communities (NYSEMKT:<a href='https://seekingalpha.com/symbol/APTS' title='Preferred Apartment Communities'>APTS</a>) reports <a href=\"https://seekingalpha.com/pr/17423519-preferred-apartment-communities-inc-reports-results-fourth-quarter-year-ended-2018\" target=\"_blank\">Q4 FFO per share</a> of 38 cents and adjusted FFO per share of 48 cents.</li><li>Beats the average analyst estimate of 37 cents.</li><li>Q4 multifamily established communities' same-store NOI of $6.62M, down 5.1% Y/Y.</li><li>Sees 2019 FFO per share of $1.44-$1.50 vs. consensus estimate of $1.60.</li><li><a href=\"http://www.pacapts.com/\" target=\"_blank\">Conference call</a> on Feb. 26 at 11:00 AM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436885-preferred-apartment-communities-beats-0_01-misses-revenue\" target=\"_blank\">Preferred Apartment Communities beats by $0.01, misses on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436892\" data-linked=\"Preferred Apartment Q4 multifamily same-store NOI -5.1%\" data-tweet=\"$APTS - Preferred Apartment Q4 multifamily same-store NOI -5.1% https://seekingalpha.com/news/3436892-preferred-apartment-q4-multifamily-store-noiminus-5_1?source=tweet\" data-url=\"https://seekingalpha.com/news/3436892-preferred-apartment-q4-multifamily-store-noiminus-5_1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436891\" data-ts=\"1551134976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436891-mosaic-on-move-after-strong-beats-in-q4-earnings-revenues\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mosaic on the move after strong beats in Q4 earnings, revenues</a></h4><ul><li>Mosaic (NYSE:<a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a>) <font color=\"green\">+3.7%</font> after-hours following a strong <a href=\"https://seekingalpha.com/news/3436861-mosaic-beats-0_20-beats-revenue\" target=\"_blank\">Q4 earnings</a> beat and doubling its annual dividend target to $0.20/share.</li><li>Q4 net sales rose to $2.5B from $2.1B in the year-ago quarter, primarily driven by the acquisition       of Vale Fertilizantes and higher realized prices, partially offset by a       decline in phosphates sales volumes; Q4 operating earnings came in at $258M, more than double $127M a year ago, as margin per ton rose in the potash, phosphates and Mosaic Fertilizantes businesses.</li><li>Q4 phosphates net sales fell 7% Y/Y to $926M, driven by a 25% decline in sales volumes reflecting lower production volumes due to the idling of the Plant City facilities, and negative weather-driven impacts to the North America fall application season; gross margin was 16% compared to 13% for the year-ago quarter.</li><li>Potash net sales rose 19% Y/Y to $592M, driven by higher average       realized sales prices and higher sales volumes; Q4 gross margin was 34% of net sales vs. 23% a year ago.</li><li>Also, net sales in the Mosaic Fertilizantes segment soared 86% to $969M, driven by higher average       realized selling prices and the acquisition of production assets from       Vale Fertilizantes; Q4 gross margin was $56/ton vs. $23/ton for the same period a year       ago.</li><li>MOS also issues in-line guidance for FY 2019, sees EPS of $2.10-$2.50 vs. $2.41 analyst consensus estimate, and initiates adjusted EBITDA guidance of $2.2B-$2.4B as well as phosphate volumes of 8.6M-9M metric tons, potash 1.7M-2M  tons, and fertilizer 1.3M-1.6M tons.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436891\" data-linked=\"Mosaic on the move after strong beats in Q4 earnings, revenues\" data-tweet=\"$MOS - Mosaic on the move after strong beats in Q4 earnings, revenues https://seekingalpha.com/news/3436891-mosaic-on-move-after-strong-beats-in-q4-earnings-revenues?source=tweet\" data-url=\"https://seekingalpha.com/news/3436891-mosaic-on-move-after-strong-beats-in-q4-earnings-revenues\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:49 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436889\" data-ts=\"1551134248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LCI\" target=\"_blank\">LCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436889-htz-immu-etsy-and-dds-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HTZ, IMMU, ETSY and DDS among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a> <font color=\"green\">+16.1%</font>. <a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a> <font color=\"green\">+11.5%</font>. <a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a> <font color=\"green\">+11.3%</font>. <a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a> <font color=\"green\">+9.8%</font>. <a href='https://seekingalpha.com/symbol/GSM' title='Ferroglobe PLC'>GSM</a> <font color=\"green\">+9.1%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/FNGR' title='FingerMotion, Inc.'>OTCPK:FNGR</a> <font color=\"red\">-16.4%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color=\"red\">-11.1%</font>. <a href='https://seekingalpha.com/symbol/MEDP' title='Medpace Holdings'>MEDP</a> <font color=\"red\">-9.6%</font>. <a href='https://seekingalpha.com/symbol/RP' title='RealPage'>RP</a> <font color=\"red\">-7.8%</font>. <a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a> <font color=\"red\">-5.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436889\" data-linked=\"HTZ, IMMU, ETSY and DDS among notable after hour movers\" data-tweet=\"$LCI $HTZ $THC - HTZ, IMMU, ETSY and DDS among notable after hour movers https://seekingalpha.com/news/3436889-htz-immu-etsy-and-dds-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3436889-htz-immu-etsy-and-dds-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436888\" data-ts=\"1551134112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEG\" target=\"_blank\">KEG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436888-key-energy-services-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Key Energy Services EPS in-line, misses on revenue</a></h4><ul><li>Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>): Q4 Non-GAAP EPS of -$1.19 in-line; GAAP EPS of -$1.14 <span style=\"color:green\">beats by $0.17</span>.</li><li>Revenue of $117.3M (+0.9% Y/Y) <font color=\"red\">misses by $6M</font>.</li><li>Shares <font color=\"green\">+8.9%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17423529-key-energy-services-reports-fourth-quarter-full-year-2018-earnings\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436888\" data-linked=\"Key Energy Services EPS in-line, misses on revenue\" data-tweet=\"$KEG - Key Energy Services EPS in-line, misses on revenue https://seekingalpha.com/news/3436888-key-energy-services-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436888-key-energy-services-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436883\" data-ts=\"1551133157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RRC\" target=\"_blank\">RRC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436883-range-resources-beats-0_17-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Range Resources beats by $0.17, beats on revenue</a></h4><ul><li>Range Resources (NYSE:<a href='https://seekingalpha.com/symbol/RRC' title='Range Resources Corporation'>RRC</a>): Q4 Non-GAAP EPS of $0.31 <span style=\"color:green\">beats by $0.17</span>; GAAP EPS of -$7.15.</li><li>Revenue of $1.07B (+57.6% Y/Y) <font color=\"green\">beats by $333.65M</font>.</li><li>Shares <font color=\"green\">+2.6%</font> AH.</li><li><a href=\"https://seekingalpha.com/pr/17423509-range-announces-fourth-quarter-year-end-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436883\" data-linked=\"Range Resources beats by $0.17, beats on revenue\" data-tweet=\"$RRC - Range Resources beats by $0.17, beats on revenue https://seekingalpha.com/news/3436883-range-resources-beats-0_17-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436883-range-resources-beats-0_17-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436881\" data-ts=\"1551132806\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RP\" target=\"_blank\">RP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436881-realpageminus-8-on-mixed-q4-downside-revenue-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RealPage -8% on mixed Q4, downside revenue outlook</a></h4><ul><li>RealPage (NASDAQ:<a href='https://seekingalpha.com/symbol/RP' title='RealPage'>RP</a>) <font color=\"red\">drops 8%</font> after reporting Q4 results that beat on EPS but missed revenue estimates despite a 21% Y/Y growth. Q1 outlook has revenue below consensus at $232.8M to $234.8M (consensus: $237.85M) and in-line EPS of $0.39 to $0.41 (consensus: $0.41).</li><li>In-line FY19 guidance has revenue from $980M to $1B (consensus: $1B) and EPS of $1.70 to $1.79 (consensus: $1.76).</li><li><a href=\"https://seekingalpha.com/pr/17423289-realpage-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Press release</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436775-realpage-beats-0_01-misses-revenue\" target=\"_blank\">RealPage beats by $0.01, misses on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436881\" data-linked=\"RealPage -8% on mixed Q4, downside revenue outlook\" data-tweet=\"$RP - RealPage -8% on mixed Q4, downside revenue outlook https://seekingalpha.com/news/3436881-realpageminus-8-on-mixed-q4-downside-revenue-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3436881-realpageminus-8-on-mixed-q4-downside-revenue-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436876\" data-ts=\"1551132602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436876-aurelius-on-windstream-chapter-11-manipulation-charges-are-nonsense\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aurelius on Windstream Chapter 11: Manipulation charges are &#39;nonsense&#39;</a></h4><ul>   <li>Aurelius Capital Management is objecting (again) to stances taken by Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>), this time in commentary along with Windstream's <a href=\"https://seekingalpha.com/news/3436708-battered-windstream-files-chapter-11-bankruptcy\" target=\"_blank\">Chapter 11 bankruptcy filing</a>.</li>    <li>Windstream chief Tony Thomas says Aurelius \"engaged in predatory market manipulation\" with its suit and credit-default swaps -- a position that Aurelius was unlikely to endure silently.</li>    <li>That accusation is \"nonsense,\" Aurelius tells Bloomberg. \"Rather than whining about us and Judge [Jesse] Furman, Windstream\u2019s management and board should engage in much-needed introspection. They alone caused the company to enter into a terrible sale-leaseback and prejudice its bondholders by breaking its promises to them,\u201d Aurelius says.</li>    <li>Aurelius <a href=\"https://seekingalpha.com/news/3434500-aurelius-trial-win-windstream-chose-bet-company-lost\" target=\"_blank\">lashed out in a similar fashion</a> after hearing Windstream's reaction to the trial loss itself.</li><li>Windstream and Aurelius were due to come together with the judge on a recommended draft judgment by today's deadline.</li>    <li>Windstream wrapped up the day <font color=\"red\">down 46.9%</font>, while Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>) <font color=\"green\">rose 14.8%</font>, breaking a four-day slide. Windstream is <font color=\"green\">up 0.7%</font> after hours on solid volume.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436876\" data-linked=\"Aurelius on Windstream Chapter 11: Manipulation charges are &#39;nonsense&#39;\" data-tweet=\"$WINMQ $UNIT - Aurelius on Windstream Chapter 11: Manipulation charges are &#39;nonsense&#39; https://seekingalpha.com/news/3436876-aurelius-on-windstream-chapter-11-manipulation-charges-are-nonsense?source=tweet\" data-url=\"https://seekingalpha.com/news/3436876-aurelius-on-windstream-chapter-11-manipulation-charges-are-nonsense\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>101&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436874\" data-ts=\"1551132460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436874-immunomedics-ceo-exits-shares-down-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics CEO exits; shares down 11%</a></h4><ul><li>Alongside Q4 results, Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) announces the exit of President and CEO Michael Pehl, due to personal reasons.</li><li>Dr. Behzad Aghazadeh has been named Executive Chairman, and Dr. Charles Baum - currently president and CEO of Mirati Therapeutics - has joined the board.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436781-immunomedics-reports-2h-results\" target=\"_blank\">Immunomedics reports 2H results</a> (Feb. 25)</li><li><a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color=\"red\">-11.1%</font> after hours</li><li><a href=\"https://www.globenewswire.com/Tracker?data=aPIEo4BUrZ9lYqytRxQ3cAc4mJgbtxcNaU1t2Byq5orKvWczsAXwWGMhR14WZnibf3wOE4t-iBCq93KC1u9xGC-rl1EdbFsT1JyUSwfbDqiAHIL1YY5keCBcNHkxe1_x\" target=\"_blank\">Conference call</a> is just underway.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436874\" data-linked=\"Immunomedics CEO exits; shares down 11%\" data-tweet=\"$IMMU - Immunomedics CEO exits; shares down 11% https://seekingalpha.com/news/3436874-immunomedics-ceo-exits-shares-down-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3436874-immunomedics-ceo-exits-shares-down-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436867\" data-ts=\"1551132032\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBD\" target=\"_blank\">DBD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436867-diebold-gamco-agree-on-board-slate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diebold, Gamco agree on board slate</a></h4><ul><li>Diebold Nixdorf (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a>)<a href=\"https://seekingalpha.com/pr/17423432-diebold-nixdorf-adds-two-new-independent-directors-2019-board-directors-slate\" target=\"_blank\"> announces</a> it will add Arthur Anton and Matthew Goldfarb to its slate of director nominees for the 2019 annual meeting. The nominations are part of the DN Now restructuring process.</li><li>Anton is chairman and CEO of Swagelok. Goldfarb founded the energy infrastructure investment firm Southport Midstream Partners.</li><li>DBD's largest shareholder Gamco agrees to support the nominees. Last November, Gamco had said it was evaluating three candidates for the board.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436867\" data-linked=\"Diebold, Gamco agree on board slate\" data-tweet=\"$DBD - Diebold, Gamco agree on board slate https://seekingalpha.com/news/3436867-diebold-gamco-agree-on-board-slate?source=tweet\" data-url=\"https://seekingalpha.com/news/3436867-diebold-gamco-agree-on-board-slate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436866\" data-ts=\"1551131882\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QTS\" target=\"_blank\">QTS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436866-qts-2019-ffo-guidance-falls-short-shares-fall-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">QTS 2019 FFO guidance falls short; shares fall AH</a></h4><ul><li>QTS Realty Trust (NYSE:<a href='https://seekingalpha.com/symbol/QTS' title='QTS Realty Trust, Inc.'>QTS</a>) sees 2019 operating FFO pre share of $2.61-$2.71, excluding joint venture impact, vs. consensus estimate of $2.76.</li><li>QTS <font color=\"red\">falls 2.1%</font> in after-hours trading.</li><li>Sees 2019 revenue of $471M-$485M, ex-joint venture impact, vs. consensus of $481.8M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436803-qts-announces-240m-jv-virginia-data-center-q4-results\" target=\"_blank\">QTS announces $240M JV for Virginia data center with Q4 results</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436866\" data-linked=\"QTS 2019 FFO guidance falls short; shares fall AH\" data-tweet=\"$QTS - QTS 2019 FFO guidance falls short; shares fall AH https://seekingalpha.com/news/3436866-qts-2019-ffo-guidance-falls-short-shares-fall-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3436866-qts-2019-ffo-guidance-falls-short-shares-fall-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436865\" data-ts=\"1551131827\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XNCR\" target=\"_blank\">XNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436865-xencor-q4-revenues-off-62-shares-down-1-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xencor Q4 revenues off 62%; shares down 1% after hours</a></h4><ul><li>Xencor (NASDAQ:<a href='https://seekingalpha.com/symbol/XNCR' title='Xencor, Inc.'>XNCR</a>) <a href=\"https://seekingalpha.com/pr/17423416-xencor-reports-fourth-quarter-full-year-2018-financial-results\" target=\"_blank\">Q4 results</a> ($M): Revenues: 11.6 (-61.6%). Drop due to milestone payments from Alexion last year.</li><li>Net income: (16.8) (-350.7%); loss/share: (0.32) (-313.3%).</li><li><strong>2019 guidance</strong>: Cash balance at year-end: $575M - 600M.</li><li>Shares are down <font color=\"red\">1%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436841-xencor-beats-0_17-beats-revenue\" target=\"_blank\">Xencor beats by $0.17, beats on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436865\" data-linked=\"Xencor Q4 revenues off 62%; shares down 1% after hours\" data-tweet=\"$XNCR - Xencor Q4 revenues off 62%; shares down 1% after hours https://seekingalpha.com/news/3436865-xencor-q4-revenues-off-62-shares-down-1-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436865-xencor-q4-revenues-off-62-shares-down-1-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436861\" data-ts=\"1551131529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MOS\" target=\"_blank\">MOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436861-mosaic-beats-0_20-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mosaic beats by $0.20, beats on revenue</a></h4><ul><li>Mosaic (NYSE:<a href='https://seekingalpha.com/symbol/MOS' title='The Mosaic Company'>MOS</a>): Q4 Non-GAAP EPS of $0.77 <span style=\"color:green\">beats by $0.20</span>; GAAP EPS of $0.29.</li><li>Revenue of $2.5B (+19.6% Y/Y) <font color=\"green\">beats by $130M</font>.</li><li>Shares <font color=\"green\">+5.8%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423469-mosaic-company-reports-fourth-quarter-full-year-2018-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436861\" data-linked=\"Mosaic beats by $0.20, beats on revenue\" data-tweet=\"$MOS - Mosaic beats by $0.20, beats on revenue https://seekingalpha.com/news/3436861-mosaic-beats-0_20-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436861-mosaic-beats-0_20-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436860\" data-ts=\"1551131505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436860-hertz-globalplus-11-after-earnings-topper\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz Global +11% after earnings topper</a></h4><ul><li>Hertz Global (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>) <font color=\"green\">jumps 10.6%</font> after posting a smaller Q4 loss than anticipated.</li><li>Revenue increased 10% during the quarter off continued U.S. RAC improvement in pricing, volume and utilization.</li><li>Total revenue per transaction day was $41.88 and Hertz's vehicle utilization rate was 81%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436852-hertz-global-holdings-beats-0_35-beats-revenue\" target=\"_blank\">Hertz Global Holdings beats by $0.35, beats on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436860\" data-linked=\"Hertz Global +11% after earnings topper\" data-tweet=\"$HTZ - Hertz Global +11% after earnings topper https://seekingalpha.com/news/3436860-hertz-globalplus-11-after-earnings-topper?source=tweet\" data-url=\"https://seekingalpha.com/news/3436860-hertz-globalplus-11-after-earnings-topper\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436852\" data-ts=\"1551131033\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTZ\" target=\"_blank\">HTZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436852-hertz-global-holdings-beats-0_35-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hertz Global Holdings beats by $0.35, beats on revenue</a></h4><ul><li>Hertz Global Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HTZ' title='Hertz Global Holdings, Inc.'>HTZ</a>): Q4 Non-GAAP EPS of -$0.55 <span style=\"color:green\">beats by $0.35</span>; GAAP EPS of -$1.20 <span style=\"color:red\">misses by $0.37</span>.</li><li>Revenue of $2.29B (+9.6% Y/Y) <font color=\"green\">beats by $140M</font>.</li><li>Shares <font color=\"green\">+10.9%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423456-hertz-global-holdings-reports-fourth-quarter-full-year-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436852\" data-linked=\"Hertz Global Holdings beats by $0.35, beats on revenue\" data-tweet=\"$HTZ - Hertz Global Holdings beats by $0.35, beats on revenue https://seekingalpha.com/news/3436852-hertz-global-holdings-beats-0_35-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436852-hertz-global-holdings-beats-0_35-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436850\" data-ts=\"1551130967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436850-tenet-q4-beat-lifts-shares-up-9-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet Q4 beat lifts shares, up 9% after hours</a></h4><ul><li>Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>) <a href=\"https://seekingalpha.com/pr/17423377-tenet-reports-results-fourth-quarter-year-ended-december-31-2018-issues-outlook-2019\" target=\"_blank\">Q4 results</a> ($M): Revenues: 4,619 (-7.2%).</li><li>Net loss: (5) (+97.8%); loss/share: (0.05) (+97.8%).</li><li>Cash flow ops (full year): 1,049 (-12.6%).</li><li><strong>Q1 guidance</strong>: Revenues: $4.3B - 4.6B; net income: ($70M - 25M); non-GAAP EBITDA: $575M - 625M; EPS: ($0.68 - 0.24); non-GAAP EPS: $0.10 - 0.43.</li><li><strong>2019 guidance</strong>: Revenues: $18.0B - 18.4B; net income: $15M - 115M; non-GAAP EBITDA: $2.65B - 2.75B; EPS: $0.14-1.08; non-GAAP EPS: $2.08 - 2.59; cash flow ops: $1.070B - 1.375B.</li><li>Shares are up <font color=\"green\">9% </font>after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436811-tenet-healthcare-beats-0_23-beats-revenue\" target=\"_blank\">Tenet Healthcare beats by $0.23, beats on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436850\" data-linked=\"Tenet Q4 beat lifts shares, up 9% after hours\" data-tweet=\"$THC - Tenet Q4 beat lifts shares, up 9% after hours https://seekingalpha.com/news/3436850-tenet-q4-beat-lifts-shares-up-9-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436850-tenet-q4-beat-lifts-shares-up-9-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436838\" data-ts=\"1551130320\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BWXT\" target=\"_blank\">BWXT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436838-bwx-technologies-beats-0_15-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BWX Technologies beats by $0.15, beats on revenue</a></h4><ul><li>BWX Technologies (NYSE:<a href='https://seekingalpha.com/symbol/BWXT' title='BWX Technologies, Inc.'>BWXT</a>): Q4 Non-GAAP EPS of $0.74 <span style=\"color:green\">beats by $0.15</span>; GAAP EPS of $0.22 <span style=\"color:red\">misses by $0.34</span>.</li><li>Revenue of $477.99M (+11.1% Y/Y) <font color=\"green\">beats by $0.92M</font>.</li><li>Shares <font color=\"green\">+3.8%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423425-bwx-technologies-concludes-2018-record-fourth-quarter-results-positioned-continued-growth\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436838\" data-linked=\"BWX Technologies beats by $0.15, beats on revenue\" data-tweet=\"$BWXT - BWX Technologies beats by $0.15, beats on revenue https://seekingalpha.com/news/3436838-bwx-technologies-beats-0_15-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436838-bwx-technologies-beats-0_15-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436835\" data-ts=\"1551130242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDS\" target=\"_blank\">DDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436835-dillardsplus-4-after-comp-sales-gain\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dillard&#39;s +4% after comp sales gain</a></h4><ul><li>Dillard's (NYSE:<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>) shoots <font color=\"green\">4.40% higher</font> after reporting total merchandise sales and comparable sales increased 2% in Q4.</li><li>Dillard's management says sales trends were strongest in home and furniture followed by cosmetics and men's clothing and accessories.</li><li>Gross margin was flat at 33.6% of sales.</li><li>Dillard's ended the quarter with an inventory position 4% higher than a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436821-dillards-reports-q4-results\" target=\"_blank\">Dillard's reports Q4 results</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436835\" data-linked=\"Dillard&#39;s +4% after comp sales gain\" data-tweet=\"$DDS - Dillard&#39;s +4% after comp sales gain https://seekingalpha.com/news/3436835-dillardsplus-4-after-comp-sales-gain?source=tweet\" data-url=\"https://seekingalpha.com/news/3436835-dillardsplus-4-after-comp-sales-gain\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436834\" data-ts=\"1551130226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/I\" target=\"_blank\">I</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436834-intelsatplus-4_8-evercore-sees-double-upside-in-share-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intelsat +4.8% as Evercore sees double upside in share price</a></h4><ul>   <li>Evercore has initiated coverage of Intelsat (NYSE:<a href='https://seekingalpha.com/symbol/I' title='Intelsat SA'>I</a>) at Outperform and sees doubling potential in the stock price.</li>    <li>Shares are <font color=\"green\">up 4.8%</font> after hours, to $25.90.</li>    <li>Evercore has set a price target at $50, 102% higher than today's close and well over average targets.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436834\" data-linked=\"Intelsat +4.8% as Evercore sees double upside in share price\" data-tweet=\"$I - Intelsat +4.8% as Evercore sees double upside in share price https://seekingalpha.com/news/3436834-intelsatplus-4_8-evercore-sees-double-upside-in-share-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3436834-intelsatplus-4_8-evercore-sees-double-upside-in-share-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436827\" data-ts=\"1551130020\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436827-endologix-q4-revenue-down-21-above-consensus-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix Q4 revenue down 21% but above consensus; shares up 2% after hours</a></h4><ul><li>Endologix (NASDAQ:<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a>) <a href=\"https://seekingalpha.com/pr/17423282-endologix-reports-fourth-quarter-fiscal-year-2018-financial-results\" target=\"_blank\">Q4 results</a> ($M): Revenue: 34.7 (-21.1%).</li><li>Net loss: (26.0) (-79.3%); loss/share: (-52.9%).</li><li><strong>Q1 guidance</strong>: Revenue: ~$35M.</li><li><strong>2019 guidance</strong>: Revenue: at least $140M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436814-endologix-misses-0_01-beats-revenue\" target=\"_blank\">Endologix misses by $0.01, beats on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436827\" data-linked=\"Endologix Q4 revenue down 21% but above consensus; shares up 2% after hours\" data-tweet=\"$ELGX - Endologix Q4 revenue down 21% but above consensus; shares up 2% after hours https://seekingalpha.com/news/3436827-endologix-q4-revenue-down-21-above-consensus-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436827-endologix-q4-revenue-down-21-above-consensus-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436821\" data-ts=\"1551129803\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDS\" target=\"_blank\">DDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436821-dillards-beats-0_61-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dillard&#39;s beats by $0.61, revenue in-line</a></h4><ul><li>Dillard's (NYSE:<a href='https://seekingalpha.com/symbol/DDS' title='Dillard&#39;s Inc.'>DDS</a>): Q4 GAAP EPS of $3.22 <font color=\"green\">beats by $0.61</font>.</li><li>Revenue of $2.01B (-2.4% Y/Y) in-line.</li><li>Shares <font color=\"green\">+5.5%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423365-dillard-s-inc-reports-fiscal-year-fourth-quarter-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436821\" data-linked=\"Dillard&#39;s beats by $0.61, revenue in-line\" data-tweet=\"$DDS - Dillard&#39;s beats by $0.61, revenue in-line https://seekingalpha.com/news/3436821-dillards-beats-0_61-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3436821-dillards-beats-0_61-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436817\" data-ts=\"1551129718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436817-shake-shackminus-4-after-restaurant-margin-falls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack -4% after restaurant margin falls</a></h4><ul><li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>) surprises with <a href=\"https://seekingalpha.com/pr/17423306-shake-shack-announces-fourth-quarter-fiscal-year-ended-2018-financial-results\" target=\"_blank\">Q4</a> comparable sales growth of +2.3% vs -1.5% consensus.</li><li>Restaurant margin came in at 22.5% of sales vs. 22.3% expected and 25.2% a year ago. Labor costs rose 160 bps to 28.5% of sales.</li><li>Shake Shack expects 2019 revenue of between $570M and $576M vs. $575M consensus off same-Shack sales of between 0% and 1%, which includes approximately 1.5% of menu price increases taken in December 2018. The company sees opening between 36 and 40 new domestic company-operated Shacks to be opened in FY19.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436789-shake-shack-beats-0_03-beats-revenue\" target=\"_blank\">Shake Shack beats by $0.03, beats on revenue</a> (Feb. 25)</li><li>SHAK <font color=\"red\">-3.60%</font> AH to $50.27 after falling 1.22% in the regular session.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436817\" data-linked=\"Shake Shack -4% after restaurant margin falls\" data-tweet=\"$SHAK - Shake Shack -4% after restaurant margin falls https://seekingalpha.com/news/3436817-shake-shackminus-4-after-restaurant-margin-falls?source=tweet\" data-url=\"https://seekingalpha.com/news/3436817-shake-shackminus-4-after-restaurant-margin-falls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436814\" data-ts=\"1551129662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELGX\" target=\"_blank\">ELGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436814-endologix-misses-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endologix misses by $0.01, beats on revenue</a></h4><ul><li>Endologix (NASDAQ:<a href='https://seekingalpha.com/symbol/ELGX' title='Endologix Inc'>ELGX</a>): Q4 GAAP EPS of -$0.26 <span style=\"color:red\">misses by $0.01</span>.</li><li>Revenue of $34.69M (-21.2% Y/Y) <font color=\"green\">beats by $2.43M</font>.</li><li>Shares <font color=\"green\">+3.57%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423282-endologix-reports-fourth-quarter-fiscal-year-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436814\" data-linked=\"Endologix misses by $0.01, beats on revenue\" data-tweet=\"$ELGX - Endologix misses by $0.01, beats on revenue https://seekingalpha.com/news/3436814-endologix-misses-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436814-endologix-misses-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436811\" data-ts=\"1551129642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436811-tenet-healthcare-beats-0_23-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet Healthcare beats by $0.23, beats on revenue</a></h4><ul><li>Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>): Q4 Non-GAAP EPS of $0.51 <span style=\"color:green\">beats by $0.23</span>; GAAP EPS of -$0.05.</li><li>Revenue of $4.6B (-7.6% Y/Y) <font color=\"green\">beats by $100M</font>.</li><li>Shares <font color=\"green\">+3.6%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423377-tenet-reports-results-fourth-quarter-year-ended-december-31-2018-issues-outlook-2019\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436811\" data-linked=\"Tenet Healthcare beats by $0.23, beats on revenue\" data-tweet=\"$THC - Tenet Healthcare beats by $0.23, beats on revenue https://seekingalpha.com/news/3436811-tenet-healthcare-beats-0_23-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436811-tenet-healthcare-beats-0_23-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436810\" data-ts=\"1551129599\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PODD\" target=\"_blank\">PODD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436810-insulet-down-after-hours-on-soft-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Insulet down after hours on soft revenue guidance</a></h4><ul><li>Insulet (NASDAQ:<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a>) <a href=\"https://seekingalpha.com/pr/17423283-insulet-reports-fourth-quarter-2018-revenue-164_9-million-26-percent-year-year-full-year-2018\" target=\"_blank\">Q4 results</a> ($M): Revenues: 164.9 (+26.4%).</li><li>Net income: 9.9 (+244.2%); EPS: 0.16 (+233.3%).</li><li><strong>Q1 guidance</strong>: Revenues: $152M - 156M; U.S. Omnipod sales: $82M - 84M; international Omnipod sales: $56M - 57M; drug delivery sales: $14M - 15M.</li><li><strong>2019 guidance</strong>: Revenues: $662M - 687M (consensus: $691.7M); U.S. Omnipod sales: $373M - 383M; international Omnipod sales: $235M - 244M; drug delivery sales: $54M - 60M.</li><li>Shares are down a fraction after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436782-insulet-beats-0_09-beats-revenue\" target=\"_blank\">Insulet beats by $0.09, beats on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436810\" data-linked=\"Insulet down after hours on soft revenue guidance\" data-tweet=\"$PODD - Insulet down after hours on soft revenue guidance https://seekingalpha.com/news/3436810-insulet-down-after-hours-on-soft-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3436810-insulet-down-after-hours-on-soft-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436790\" data-ts=\"1551128976\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436790-vistagen-readies-stock-offering-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen readies stock offering; shares down 3% after hours</a></h4><ul><li>VistaGen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a>) is down <font color=\"red\">3%</font> after hours in response to its planned <a href=\"https://seekingalpha.com/pr/17423290-vistagen-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436790\" data-linked=\"VistaGen readies stock offering; shares down 3% after hours\" data-tweet=\"$VTGN - VistaGen readies stock offering; shares down 3% after hours https://seekingalpha.com/news/3436790-vistagen-readies-stock-offering-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436790-vistagen-readies-stock-offering-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436789\" data-ts=\"1551128959\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHAK\" target=\"_blank\">SHAK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436789-shake-shack-beats-0_03-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shake Shack beats by $0.03, beats on revenue</a></h4><ul><li>Shake Shack (NYSE:<a href='https://seekingalpha.com/symbol/SHAK' title='Shake Shack'>SHAK</a>): Q4 Non-GAAP EPS of $0.06 <span style=\"color:green\">beats by $0.03</span>; GAAP EPS of -$0.03 <span style=\"color:red\">misses by $0.05</span>.</li><li>Revenue of $124.3M (+29.3% Y/Y) <font color=\"green\">beats by $5.2M</font>.</li><li>Shares <font color=\"green\">+6.2%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423306-shake-shack-announces-fourth-quarter-fiscal-year-ended-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436789\" data-linked=\"Shake Shack beats by $0.03, beats on revenue\" data-tweet=\"$SHAK - Shake Shack beats by $0.03, beats on revenue https://seekingalpha.com/news/3436789-shake-shack-beats-0_03-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436789-shake-shack-beats-0_03-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436785\" data-ts=\"1551128880\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLS\" target=\"_blank\">NLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436785-nautilus-beats-0_01-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nautilus beats by $0.01, beats on revenue</a></h4><ul><li>Nautilus (NYSE:<a href='https://seekingalpha.com/symbol/NLS' title='Nautilus, Inc.'>NLS</a>): Q4 GAAP EPS of $0.05 <span style=\"color:green\">beats by $0.01</span>.</li><li>Revenue of $115.38M (-9.7% Y/Y) <font color=\"green\">beats by $0.67M</font>.</li><li>Shares <font color=\"green\">+1.87%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423295-nautilus-inc-reports-results-fourth-quarter-full-year-2018\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436785\" data-linked=\"Nautilus beats by $0.01, beats on revenue\" data-tweet=\"$NLS - Nautilus beats by $0.01, beats on revenue https://seekingalpha.com/news/3436785-nautilus-beats-0_01-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436785-nautilus-beats-0_01-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436784\" data-ts=\"1551128879\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RARE\" target=\"_blank\">RARE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436784-ultragenyx-launches-250m-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ultragenyx launches $250M stock offering</a></h4><ul><li>Ultragenyx (NASDAQ:<a href='https://seekingalpha.com/symbol/RARE' title='Ultragenyx Pharmaceutical Inc.'>RARE</a>) <a href=\"https://seekingalpha.com/pr/17423274-ultragenyx-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a $250M public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436784\" data-linked=\"Ultragenyx launches $250M stock offering\" data-tweet=\"$RARE - Ultragenyx launches $250M stock offering https://seekingalpha.com/news/3436784-ultragenyx-launches-250m-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3436784-ultragenyx-launches-250m-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436778\" data-ts=\"1551128739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVCN\" target=\"_blank\">NVCN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436778-neovasc-readies-stock-offering-shares-down-12-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Neovasc readies stock offering; shares down 12% after hours</a></h4><ul><li>Neovasc (NASDAQ:<a href='https://seekingalpha.com/symbol/NVCN' title='Neovasc Inc.'>NVCN</a>) is down <font color=\"red\">12%</font> after hours in response to its planned <a href=\"https://seekingalpha.com/pr/17423262-neovasc-announces-proposed-public-offering-common-shares\" target=\"_blank\">stock offering</a>. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436778\" data-linked=\"Neovasc readies stock offering; shares down 12% after hours\" data-tweet=\"$NVCN - Neovasc readies stock offering; shares down 12% after hours https://seekingalpha.com/news/3436778-neovasc-readies-stock-offering-shares-down-12-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436778-neovasc-readies-stock-offering-shares-down-12-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436776\" data-ts=\"1551128724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETSY\" target=\"_blank\">ETSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436776-etsy-beats-0_12-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Etsy beats by $0.12, beats on revenue</a></h4><ul><li>Etsy (NASDAQ:<a href='https://seekingalpha.com/symbol/ETSY' title='Etsy, Inc.'>ETSY</a>): Q4 GAAP EPS of $0.32 <span style=\"color:green\">beats by $0.12</span>.</li><li>Revenue of $200.03M (+46.8% Y/Y) <font color=\"green\">beats by $5.16M</font>.</li><li>Shares <font color=\"green\">+10.07%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17423292-etsy-inc-reports-fourth-quarter-full-year-2018-financial-results\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436776\" data-linked=\"Etsy beats by $0.12, beats on revenue\" data-tweet=\"$ETSY - Etsy beats by $0.12, beats on revenue https://seekingalpha.com/news/3436776-etsy-beats-0_12-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3436776-etsy-beats-0_12-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436772\" data-ts=\"1551128643\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAGE\" target=\"_blank\">SAGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436772-sage-therapeutics-launches-500m-stock-offering-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sage Therapeutics launches $500M stock offering; shares down 3% after hours</a></h4><ul><li>Sage Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a>) <a href=\"https://seekingalpha.com/pr/17423272-sage-therapeutics-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of $500M of common stock. Price, volume and terms have yet to be announced.</li><li>Shares are down <font color=\"red\">3%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436772\" data-linked=\"Sage Therapeutics launches $500M stock offering; shares down 3% after hours\" data-tweet=\"$SAGE - Sage Therapeutics launches $500M stock offering; shares down 3% after hours https://seekingalpha.com/news/3436772-sage-therapeutics-launches-500m-stock-offering-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3436772-sage-therapeutics-launches-500m-stock-offering-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436768\" data-ts=\"1551128066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CELTF\" target=\"_blank\">CELTF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436768-centaminminus-25-q4-results-2019-guidance-disappoints\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Centamin -25% as Q4 results, 2019 guidance disappoints</a></h4><ul><li>Centamin (<a href='https://seekingalpha.com/symbol/CELTF' title='Centamin PLC'>OTCPK:CELTF</a> <font color='red'>-25.3%</font>) shares fall by the most in six years after <a href=\"https://seekingalpha.com/news/3436431-centamin-reports-q4-results\" target=\"_blank\">Q4 EBITDA</a> sinks 35% Y/Y to $50.5M and revenues fall 4.5% to $182M, driven by a 3% drop in gold sales of to 148.8K oz.</li><li>For the full year, the company\u2019s flagship Sukari mine in Egypt delivered 472.4K oz. of gold, a 13% Y/Y decline, at a $624/oz. cash cost of production and $884/oz. all-in sustaining cost, which were a higher than the prior year by a respective 13% and 12%.</li><li>Investors also are disappointed in the company's guidance for 2019 production of 490K-520K oz. of gold, with increased stripping in the open pit balanced by estimated higher average grades.</li><li>Centamin also forecasts 2019 cash cost of production at $675-$725/oz. and AISC of $890-$950/oz. sold.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436768\" data-linked=\"Centamin -25% as Q4 results, 2019 guidance disappoints\" data-tweet=\"$CELTF - Centamin -25% as Q4 results, 2019 guidance disappoints https://seekingalpha.com/news/3436768-centaminminus-25-q4-results-2019-guidance-disappoints?source=tweet\" data-url=\"https://seekingalpha.com/news/3436768-centaminminus-25-q4-results-2019-guidance-disappoints\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436759\" data-ts=\"1551125676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AG\" target=\"_blank\">AG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436759-first-majestic-silverplus-4-q4-not-bad-feared-amid-weaker-silver-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Majestic Silver +4% as Q4 not as bad as feared amid weaker silver price</a></h4><ul><li>First Majestic Silver (<a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='green'>+4.1%</font>) is higher after reporting an expected <a href=\"https://seekingalpha.com/news/3436451-first-majestic-silver-eps-line-misses-revenue\" target=\"_blank\">Q4 loss</a> and a 21% Y/Y revenue increase, as results may have been better than feared the miner realized a nine-year low in quarterly average silver price.</li><li>Q4 silver production soared 39% Y/Y to 3.25M oz. at all-in sustaining costs of $12.83/oz., 9% lower than the year-ago quarter, plus 34.5K oz. of gold, 3.3M lbs. of lead and  1.4M lbs. of zinc for a total of 6.5M silver equiv. oz.</li><li>AG says its Q4 average realized silver price of $14.47/oz. fell 13% from $16.61/oz. in the year-ago quarter.</li><li>Q4 mine operations lost $9M vs. a $1.4M gain a year ago, reflecting a $7.5M inventory loss due to the bankruptcy of Republic Metals, tighter  margins from the lower average silver price and $1M in severance costs as part of a staff reduction.</li><li>President and CEO Keith Meumeyer calls drilling results from the company's Ermitaño project in Mexico \"<a href=\"https://seekingalpha.com/pr/17422312-first-majestic-announces-high-grade-drill-results-2018-exploration-program-ermitano-silver\" target=\"_blank\">extremely  encouraging</a> as it continues to show the potential to build high quality  resources in close proximity to our producing Santa Elena operation.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3436759\" data-linked=\"First Majestic Silver +4% as Q4 not as bad as feared amid weaker silver price\" data-tweet=\"$AG - First Majestic Silver +4% as Q4 not as bad as feared amid weaker silver price https://seekingalpha.com/news/3436759-first-majestic-silverplus-4-q4-not-bad-feared-amid-weaker-silver-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3436759-first-majestic-silverplus-4-q4-not-bad-feared-amid-weaker-silver-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436757\" data-ts=\"1551125422\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRKR\" target=\"_blank\">MRKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436757-marker-therapeutics-up-10-on-multitaa-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marker Therapeutics up 10% on MultiTAA data</a></h4><ul><li>Thinly traded micro cap Marker Therapeutics (<a href='https://seekingalpha.com/symbol/MRKR' title='Marker Therapeutics Inc'>MRKR</a> <font color=\"green\">+9.5%</font>) is up on double normal volume, albeit on turnover of only 575K shares, on the heels of <a href=\"https://seekingalpha.com/pr/17422241-marker-therapeutics-announces-clinical-update-transplantation-and-cellular-therapy-meetings\" target=\"_blank\">updated data</a> on its multi-antigen targeted T cell (MultiTAA) therapies in blood cancer studies. The results were presented the Transplantation &amp; Cellular Therapy Meetings in Houston, TX.</li><li>The data are based on 78 participants, up from 57 reported in November 2018.</li><li>85% (n=11/13) of AML patients in Arm A dosed with MultiTAA cells as maintenance therapy after allogeneic stem cell transplantation remain alive (six weeks to 2.5 years post-infusion). Nine have not relapsed.</li><li>Patients in Arm B with relapsed/refractory AML showed a 33% (n=2/6) response rate, including one complete response that was durable for 13 months. Two patients failed to respond and progressed and two others experienced stable cancer implying a 67% disease control rate.</li><li>Results from ongoing studies in ALL and multiple myeloma showed that patients have remained in continue complete remission &#40;CCR&#41; for up to 28 months.</li><li>The company says its <a href=\"https://markertherapeutics.com/multitaa-technology/\" target=\"_blank\">MultiTAA </a>cells are more effective than other cell therapies because they recognize up to five different tumor-associated antigens instead of just one.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436757\" data-linked=\"Marker Therapeutics up 10% on MultiTAA data\" data-tweet=\"$MRKR - Marker Therapeutics up 10% on MultiTAA data https://seekingalpha.com/news/3436757-marker-therapeutics-up-10-on-multitaa-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3436757-marker-therapeutics-up-10-on-multitaa-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436752\" data-ts=\"1551124807\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436752-microcaps-dominate-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate tech movers</a></h4><ul><li><strong>Gainers:</strong> Phoenix New Media (NYSE:<a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a>) <font color=\"green\">+24%</font>. Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>) <font color=\"green\">+21%</font>. Stamps.com (NASDAQ:<a href='https://seekingalpha.com/symbol/STMP' title='Stamps.com Inc.'>STMP</a>) <font color=\"green\">+18%</font>. SPI Energy (NASDAQ:<a href='https://seekingalpha.com/symbol/SPI' title='SPI Energy Co., Ltd.'>SPI</a>) <font color=\"green\">+11%</font>. MicroVision (NASDAQ:<a href='https://seekingalpha.com/symbol/MVIS' title='Microvision, Inc.'>MVIS</a>) <font color=\"green\">+10%</font>.</li><li><strong>Losers: </strong>Travelzoo (NASDAQ:<a href='https://seekingalpha.com/symbol/TZOO' title='Travelzoo Inc'>TZOO</a>) <font color=\"red\">-15%</font>. Asure Software (NASDAQ:<a href='https://seekingalpha.com/symbol/ASUR' title='Asure Software, Inc.'>ASUR</a>) <font color=\"red\">-8%</font>. Cool Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a>) <font color=\"red\">-6%</font>. ATN International (NASDAQ:<a href='https://seekingalpha.com/symbol/ATNI' title='ATN International, Inc.'>ATNI</a>) <font color=\"red\">-6%</font>. B.O.S Better Online Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/BOSC' title='B.O.S. Better Online Solutions'>BOSC</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436752\" data-linked=\"Microcaps dominate tech movers\" data-tweet=\"$FENG $VERI $STMP - Microcaps dominate tech movers https://seekingalpha.com/news/3436752-microcaps-dominate-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3436752-microcaps-dominate-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436751\" data-ts=\"1551124433\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THS\" target=\"_blank\">THS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436751-wells-fargo-confident-on-treehouse-foods-after-cagny-talk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo confident on TreeHouse Foods after CAGNY talk</a></h4><ul> <li>Wells Fargo updates on TreeHouse Foods (<a href='https://seekingalpha.com/symbol/THS' title='TreeHouse Foods, Inc.'>THS</a> <font color='red'>-1.1%</font>) after taking in the company's presentation at the CAGNY investor conference.</li> <li>\"We came away increasingly confident about management's visibility into business stabilization and new business materializing during 2H19. Cost savings execution remains on track (the TMOS program rolls out to 12 more plants in FY19) and much improved service levels are restoring retail customers' willingness to engage,\" notes WF.</li> <li>TreeHouse is rated at Market Perform by the firm.</li><li>Shares of THS are up 19% YTD.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436751\" data-linked=\"Wells Fargo confident on TreeHouse Foods after CAGNY talk\" data-tweet=\"$THS - Wells Fargo confident on TreeHouse Foods after CAGNY talk https://seekingalpha.com/news/3436751-wells-fargo-confident-on-treehouse-foods-after-cagny-talk?source=tweet\" data-url=\"https://seekingalpha.com/news/3436751-wells-fargo-confident-on-treehouse-foods-after-cagny-talk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436722\" data-ts=\"1551122396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436722-ge-debt-rallies-credit-default-swaps-tumble-on-danaher-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GE debt rallies, credit default swaps tumble on Danaher deal</a></h4><ul><li>General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='green'>+8.2%</font>) bonds are <a href=\"https://www.reuters.com/article/us-ge-divestiture-danaher-bonds/ge-debt-rallies-bond-insurance-price-drops-on-danaher-deal-idUSKCN1QE2AC?il=0\" target=\"_blank\">rallying broadly</a> following the company's <a href=\"https://seekingalpha.com/news/3436455-ge-sell-biopharma-unit-danaher-21_4b\" target=\"_blank\">$21.4B deal</a> to sell its biopharma business to Danaher and saying it will use cash from the deal to ease its massive debt burden.</li><li>Yields on GE bonds fell to the lowest in about four months across dozens of debt securities, the risk premium demanded by investors in exchange for holding GE paper declined, and the five-year credit default swaps reportedly <a href=\"https://finance.yahoo.com/news/ge-surges-agreeing-21-4-133527545.html\" target=\"_blank\">tumbled 25 bps</a> in their largest one-day drop in at least three years.</li><li>One of GE\u2019s most active bonds - its $11.5B of 4.418% notes due in November 2035 - jumped 2.6 points in price to regain the $0.90 on the dollar level for the first time since October; in mid-November, they had dropped to as low as $0.77 on the dollar.</li><li>Meanwhile, GE shares enjoy strong gains but remain on track to extend a 526-session streak below the 200-day moving average, the <a href=\"https://www.marketwatch.com/story/ge-stock-rockets-after-21-billion-deal-with-danaher-but-remains-below-key-chart-level-2019-02-25\" target=\"_blank\">longest known stretch in at least 40 years</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436722\" data-linked=\"GE debt rallies, credit default swaps tumble on Danaher deal\" data-tweet=\"$GE - GE debt rallies, credit default swaps tumble on Danaher deal https://seekingalpha.com/news/3436722-ge-debt-rallies-credit-default-swaps-tumble-on-danaher-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3436722-ge-debt-rallies-credit-default-swaps-tumble-on-danaher-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436720\" data-ts=\"1551122135\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAWW\" target=\"_blank\">AAWW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436720-atlas-air-lower-after-fatal-plane-crash\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atlas Air lower after fatal plane crash</a></h4><ul> <li>Atlas Air Worldwide Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/AAWW' title='Atlas Air Worldwide Holdings'>AAWW</a>) is <font color=\"red\">down 5.45%</font> after the tragic death of three of the company's pilots on a cargo flight that crashed on Saturday.</li> <li>Video shows the Boeing 767-300 in a steep dive right before the crash into a marshy area outside of Houston.</li> <li>Atlas Air says it's assisting the FAA with the investigation.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3436720\" data-linked=\"Atlas Air lower after fatal plane crash\" data-tweet=\"$AAWW - Atlas Air lower after fatal plane crash https://seekingalpha.com/news/3436720-atlas-air-lower-after-fatal-plane-crash?source=tweet\" data-url=\"https://seekingalpha.com/news/3436720-atlas-air-lower-after-fatal-plane-crash\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436716\" data-ts=\"1551121747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436716-windstream-resumes-from-bankruptcy-halt-down-38-unitplus-13_8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream resumes from bankruptcy halt, down 38%; UNIT +13.8%</a></h4><ul>   <li>Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) -- previously halted in preparation for a now-filed Chapter 11 bankruptcy petition -- has resumed trading and is now <font color=\"red\">down 37.9%</font>.</li>    <li>Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>), which gets most of its revenue from a Windstream master lease, moved into positive ground once the bankruptcy was officially filed, was halted again for volatility, and is now <font color=\"green\">up 13.8%</font>.</li>    <li>The filing came after a \"comprehensive\" review of Windstream's options, CEO Tony Thomas says.</li>    <li>But he was <a href=\"https://seekingalpha.com/pr/17423124-windstream-holdings-inc-files-voluntary-reorganization-chapter-11-u-s-bankruptcy-code\" target=\"_blank\">critical of the decisio</a>n that brought the company here: \"Windstream strongly disagrees with Judge Furman\u2019s decision,\u201d and the company thinks Aurelius \"engaged in predatory market manipulation to advance its own financial position through credit default swaps at the expense of many thousands of shareholders, lenders, employees, customers, vendors and partners.\"</li>    <li>The time is \"well past for regulators to carefully examine ramifications of an unregulated credit default swap marketplace,\" Thomas says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436716\" data-linked=\"Windstream resumes from bankruptcy halt, down 38%; UNIT +13.8%\" data-tweet=\"$WINMQ $UNIT - Windstream resumes from bankruptcy halt, down 38%; UNIT +13.8% https://seekingalpha.com/news/3436716-windstream-resumes-from-bankruptcy-halt-down-38-unitplus-13_8?source=tweet\" data-url=\"https://seekingalpha.com/news/3436716-windstream-resumes-from-bankruptcy-halt-down-38-unitplus-13_8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>69&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436714\" data-ts=\"1551121622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARQL\" target=\"_blank\">ARQL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436714-arqule-up-3-on-miransertib-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule up 3% on miransertib data</a></h4><ul><li>ArQule (<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a> <font color=\"green\">+3.3%</font>) is up on below-average volume in response to <a href=\"https://seekingalpha.com/pr/17422217-arqule-announces-publication-clinical-data-miransertib-proteus-syndrome\" target=\"_blank\">preliminary data</a> on miransertib in patients with Proteus syndrome, an ultra-rare condition characterized by abnormal overgrowth of multiple tissue which changes the shape of body structures over time.The results were just published in the <em>American Journal of Human Genetics</em>.</li><li>100% (n=3/3) of pediatric patients experienced lower pain intensity. Reductions in skin lesions (size, depth and discomfort) were also noted. The safety profile was favorable.</li><li>Miransertib (ARQ 092) is an orally available inhibitor of protein kinase B (and potentially other kinases) whose dysregulation is associated with overgrowth disorders and cancers.</li><li>Development is ongoing.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436714\" data-linked=\"ArQule up 3% on miransertib data\" data-tweet=\"$ARQL - ArQule up 3% on miransertib data https://seekingalpha.com/news/3436714-arqule-up-3-on-miransertib-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3436714-arqule-up-3-on-miransertib-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436713\" data-ts=\"1551121154\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436713-kosmos-energy-and-torchlight-energy-resources-among-energy-materials-gainers-ramaco-resources\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kosmos Energy and Torchlight Energy Resources among Energy/Materials gainers; Ramaco Resources and Pioneer Energy Services among losers</a></h4><ul><li><b>Gainers: </b>Kosmos Energy (NYSE:<a href='https://seekingalpha.com/symbol/KOS' title='Kosmos Energy'>KOS</a>) <font color=\"green\">+11%</font>. Torchlight Energy Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/TRCH' title='Torchlight Energy Resources, Inc.'>TRCH</a>) <font color=\"green\">+11%</font>. Key Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/KEG' title='Key Energy Services, Inc.'>KEG</a>) <font color=\"green\">+10%</font>. Synalloy (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNL' title='Synalloy Corporation'>SYNL</a>) <font color=\"green\">+10%</font>. Flexible Solutions International (NYSEMKT:<a href='https://seekingalpha.com/symbol/FSI' title='Flexible Solutions International, Inc'>FSI</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Ramaco Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/METC' title='Ramaco'>METC</a>) <font color=\"red\">-11%</font>. Pioneer Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a>) <font color=\"red\">-7%</font>. Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"red\">-7%</font>. Mountain Province Diamonds (NYSEMKT:<a href='https://seekingalpha.com/symbol/MPVD' title='Mountain Province Diamonds, Inc'>MPVD</a>) <font color=\"red\">-6%</font>. Northern Oil and Gas (NYSEMKT:<a href='https://seekingalpha.com/symbol/NOG' title='Northern Oil & Gas, Inc'>NOG</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436713\" data-linked=\"Kosmos Energy and Torchlight Energy Resources among Energy/Materials gainers; Ramaco Resources and Pioneer Energy Services among losers\" data-tweet=\"$KOS $TRCH $KEG - Kosmos Energy and Torchlight Energy Resources among Energy/Materials gainers; Ramaco Resources and Pioneer Energy Services among losers https://seekingalpha.com/news/3436713-kosmos-energy-and-torchlight-energy-resources-among-energy-materials-gainers-ramaco-resources?source=tweet\" data-url=\"https://seekingalpha.com/news/3436713-kosmos-energy-and-torchlight-energy-resources-among-energy-materials-gainers-ramaco-resources\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436712\" data-ts=\"1551120951\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MCC\" target=\"_blank\">MCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436712-medley-capital-medley-management-drop-amid-shareholders-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Medley Capital, Medley Management drop amid shareholder&#39;s concerns</a></h4><ul><li>Medley Capital (<a href='https://seekingalpha.com/symbol/MCC' title='Medley Capital'>MCC</a> <font color='red'>-4.3%</font>) and Medley Management (<a href='https://seekingalpha.com/symbol/MDLY' title='Medley Management'>MDLY</a> <font color='red'>-3.6%</font>) decline after FrontFour Capital Group, a shareholder in MCC, repeats \"serious concerns\" about the proposed merger of MCC, MDLY and Sierra Income Corp.</li><li>FrontFour notes that ISS continues to recommend that shareholders vote against the proposed transaction and questions the apparent unwillingness of MCC to talk with NexPoint Advisors.</li><li>FrontFour<a href=\"https://seekingalpha.com/pr/17422911-iss-affirms-recommendation-vote-combination-medley-capital-sierra-medley-management\" target=\"_blank\"> filed a lawsuit</a> on Feb. 11, 2019 alleging breach of fiduciary duty against the MCC board. If the injunction it seeks is granted, it will strike the merger agreement's no solicitation clause and termination fee.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3434142-medley-capital-urges-iss-revert-original-recommendation\" target=\"_blank\">Medley Capital urges ISS to revert to its original recommendation</a> (Feb. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436712\" data-linked=\"Medley Capital, Medley Management drop amid shareholder&#39;s concerns\" data-tweet=\"$MCC $MDLY - Medley Capital, Medley Management drop amid shareholder&#39;s concerns https://seekingalpha.com/news/3436712-medley-capital-medley-management-drop-amid-shareholders-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3436712-medley-capital-medley-management-drop-amid-shareholders-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436709\" data-ts=\"1551120513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIDX\" target=\"_blank\">EIDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436709-eidos-therapeutics-webcast-wednesday-on-late-stage-plan-for-ag10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eidos Therapeutics webcast Wednesday on late-stage plan for AG10</a></h4><ul><li>Eidos Therapeutics (<a href='https://seekingalpha.com/symbol/EIDX' title='Eidos Therapeutics'>EIDX</a> <font color=\"green\">+2.6%</font>) will host a <a href=\"https://seekingalpha.com/pr/17422488-eidos-therapeutics-host-conference-call-webcast-discuss-attr-cm-phase-3-trial-attribute-cm\" target=\"_blank\">conference call</a> and webcast on Wednesday, February 28, at 8:00 am ET to discuss its Phase 3 program for AG10 in patients with ATTR cardiomyopathy and to provide a business update.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436709\" data-linked=\"Eidos Therapeutics webcast Wednesday on late-stage plan for AG10\" data-tweet=\"$EIDX - Eidos Therapeutics webcast Wednesday on late-stage plan for AG10 https://seekingalpha.com/news/3436709-eidos-therapeutics-webcast-wednesday-on-late-stage-plan-for-ag10?source=tweet\" data-url=\"https://seekingalpha.com/news/3436709-eidos-therapeutics-webcast-wednesday-on-late-stage-plan-for-ag10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436708\" data-ts=\"1551120062\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436708-battered-windstream-files-for-chapter-11-bankruptcy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Battered Windstream files for Chapter 11 bankruptcy</a></h4><ul>   <li>Windstream Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) has filed a petition for Chapter 11 bankruptcy in the Southern District of New York.</li>    <li>Shares are still on a halt from earlier pending news, <font color=\"red\">down 24.3%</font>, but have been updated to \"news disseminated\" and don't yet have a resumption time set.</li>    <li>Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>) -- linked to Windstream through a key master lease -- was down on <a href=\"https://seekingalpha.com/news/3436626-windstream-minus-25-percent-reports-bankruptcy-prep-unit-minus-5_3-percent-updated-new-halt\" target=\"_blank\">earlier reports the filing was imminent</a>, but has turned higher, <font color=\"green\">up 2.1%</font> and rising.</li><li>Windstream plans to use a court-supervised process to address the accelerated debt maturities coming from its default-trial loss against Aurelius. It's \"committed to operating its business as usual\" and has secured $1B from Citi in debtor-in-possession financing to support operations.</li><li>Windstream's market cap is down to $27.7M as of the halt.</li><li><strong>Updated:</strong> <a href=\"https://seekingalpha.com/pr/17423124-windstream-holdings-inc-files-voluntary-reorganization-chapter-11-u-s-bankruptcy-code\" target=\"_blank\">Press release</a></li><li><strong>Updated 1:47 p.m.: </strong>Windstream will resume quotes at 2 p.m. ET and resume trading at 2:05 p.m.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436708\" data-linked=\"Battered Windstream files for Chapter 11 bankruptcy\" data-tweet=\"$WINMQ $UNIT - Battered Windstream files for Chapter 11 bankruptcy https://seekingalpha.com/news/3436708-battered-windstream-files-for-chapter-11-bankruptcy?source=tweet\" data-url=\"https://seekingalpha.com/news/3436708-battered-windstream-files-for-chapter-11-bankruptcy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>113&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436705\" data-ts=\"1551119426\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436705-facebook-responds-verge-piece-highlights-moderator-work-conditions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook responds as Verge piece highlights moderator work conditions</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+1.9%</font>) is responding to a <a href=\"https://www.theverge.com/2019/2/25/18229714/cognizant-facebook-content-moderator-interviews-trauma-working-conditions-arizona\" target=\"_blank\">Verge expose</a> of the shocking content and tough working conditions faced by the company's moderators and reviewers (who tend to work for one of a few contract firms).</li>    <li>Professional services vendors including Cognizant (<a href=\"http://seekingalpha.com/symbol/CTSH\" target=\"_blank\">CTSH</a> <font color=\"red\">-0.2%</font>) employ moderators to review content including violence and sex, under heavy nondisclosure agreements made to protect user privacy but which also insulates the companies from criticism about working conditions, moderators say.</li>    <li>Addressing the report, Facebook <a href=\"https://newsroom.fb.com/news/2019/02/commitment-to-content-reviewers/\" target=\"_blank\">defends its use of contractors</a> from Cognizant, Accenture (<a href=\"http://seekingalpha.com/symbol/ACN\" target=\"_blank\">ACN</a> <font color=\"green\">+0.3%</font>) and Genpact (<a href=\"http://seekingalpha.com/symbol/G\" target=\"_blank\">G</a> <font color=\"green\">+0.7%</font>) because of their core competencies, and emphasizes that it's committed to working with partners to \"demand a high level of support for their employees.\"</li>    <li>Those contract firms not only allow Facebook to scale more quickly globally, The Verge says, but to do so on a radically cheaper basis: The media Facebook employee earns $240K annually, while a content moderator working for Cognizant in Arizona will make just $28,800/year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436705\" data-linked=\"Facebook responds as Verge piece highlights moderator work conditions\" data-tweet=\"$FB $CTSH $ACN - Facebook responds as Verge piece highlights moderator work conditions https://seekingalpha.com/news/3436705-facebook-responds-verge-piece-highlights-moderator-work-conditions?source=tweet\" data-url=\"https://seekingalpha.com/news/3436705-facebook-responds-verge-piece-highlights-moderator-work-conditions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436665\" data-ts=\"1551116862\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436665-ericssons-ekholm-touts-companys-2019-5g-rollouts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson&#39;s Ekholm touts company&#39;s 2019 5G rollouts</a></h4><ul>   <li>Kicking off Ericsson's (<a href=\"http://seekingalpha.com/symbol/ERIC\" target=\"_blank\">ERIC</a> <font color=\"red\">-2.9%</font>) Mobile World Congress, CEO Börje Ekholm recounts that the company has publicly announced 5G deal with <a href=\"https://seekingalpha.com/pr/17422055-borje-ekholm-ericsson-switch-5g-globally-2019\" target=\"_blank\">10 named service providers</a> and is at work on 5G rollouts in the United States, Europe, Asia and Australia.</li>    <li>\"We are truly switching on 5G around the world in 2019,\" Ekholm says.</li>    <li>According to Ericsson's research, he adds that a third of global smartphone users will change either immediately or within six months to a provider that switches on 5G -- amplifying the high stakes for carriers who are racing toward claiming 5G milestones.</li>    <li>And while he says the tech will transform the industry into the industrial Internet, the first commercial-scale beneficiaries will be mobile broadband consumers as new applications arrive in augmented reality/virtual reality.</li>    <li>The company also said it's acquiring Kathrein's antenna/filters business, a move that will expand its Radio System portfolio and strengthen in-house competence. Kathrein is currently an Ericsson supplier.</li>    <li>That deal's expected to close in Q3 and financial terms weren't disclosed; preliminary revenues from the acquired part were about \u20ac270M in 2018 excluding sales to Ericsson.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436665\" data-linked=\"Ericsson&#39;s Ekholm touts company&#39;s 2019 5G rollouts\" data-tweet=\"$ERIC - Ericsson&#39;s Ekholm touts company&#39;s 2019 5G rollouts https://seekingalpha.com/news/3436665-ericssons-ekholm-touts-companys-2019-5g-rollouts?source=tweet\" data-url=\"https://seekingalpha.com/news/3436665-ericssons-ekholm-touts-companys-2019-5g-rollouts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436663\" data-ts=\"1551116797\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436663-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul><li><strong>Gainers: </strong>China Internet Nationwide Financial Services (NASDAQ:<a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a>) <font color=\"green\">+137%</font>. Spark Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a>) <font color=\"green\">+120%</font>. Clementia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTA' title='Clementia Pharmaceuticals'>CMTA</a>) <font color=\"green\">+74%</font>. uniQure N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) <font color=\"green\">+30%</font>. Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) <font color=\"green\">+27%</font>. CRISPR Therapeutics AG (NASDAQ:<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a>) <font color=\"green\">+26%</font>. Phoenix New Media Limited (NYSE:<a href='https://seekingalpha.com/symbol/FENG' title='Phoenix New Media Limited'>FENG</a>) <font color=\"green\">+25%</font>. Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp'>PLAG</a>) <font color=\"green\">+19%</font>. AVROBIO (NASDAQ:<a href='https://seekingalpha.com/symbol/AVRO' title='AVROBIO'>AVRO</a>) <font color=\"green\">+19%</font>. Akcea Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AKCA' title='Akcea Therapeutics'>AKCA</a>) <font color=\"green\">+17%</font>.</li> <li><strong>Losers: </strong>Sky Solar Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SKYS' title='Sky Solar Holdings'>SKYS</a>) <font color=\"red\">-24%</font>. Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <font color=\"red\">-23%</font>. Sunlands Online Education Group (NYSE:<a href='https://seekingalpha.com/symbol/STG' title='Sunlands Online Education'>STG</a>) <font color=\"red\">-20%</font>. Genworth Financial (NYSE:<a href='https://seekingalpha.com/symbol/GNW' title='Genworth Financial, Inc.'>GNW</a>) <font color=\"red\">-14%</font>. Industrial Services of America (NASDAQ:<a href='https://seekingalpha.com/symbol/IDSA' title='Industrial Services of America, Inc.'>IDSA</a>) <font color=\"red\">-11%</font>. Hoth Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/HOTH' title='Hoth Therapeutics, Inc.'>HOTH</a>) <font color=\"red\">-11%</font>. Ramaco Resources (NASDAQ:<a href='https://seekingalpha.com/symbol/METC' title='Ramaco'>METC</a>) <font color=\"red\">-11%</font>. OncoCyte Corporation (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-10%</font>. Textainer Group Holdings (NYSE:<a href='https://seekingalpha.com/symbol/TGH' title='Textainer Group Holdings Limited'>TGH</a>) <font color=\"red\">-10%</font>. Reebonz Holding Limited (<a href='https://seekingalpha.com/symbol/RBZ' title='Reebonz Holding Ltd. Class A'>RBZ</a>) <font color=\"red\">-9%</font>. XpresSpa Group (NASDAQ:<a href='https://seekingalpha.com/symbol/XSPA' title='XpresSpa Group'>XSPA</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436663\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CIFS $ONCE $CMTA - Midday Gainers / Losers https://seekingalpha.com/news/3436663-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3436663-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436658\" data-ts=\"1551116291\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYME\" target=\"_blank\">TYME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436658-tyme-tech-down-6-on-development-path-for-smminus-88-in-pancreatic-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tyme Tech down 6% on development path for SM-88 in pancreatic cancer</a></h4><ul><li>Tyme Technologies (<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a> <font color=\"red\">-6%</font>) is down on below-average volume after the company <a href=\"https://seekingalpha.com/pr/17422486-tyme-receives-fda-guidance-pivotal-trial-smminus-88-treatment-advanced-pancreatic-cancer\" target=\"_blank\">announced</a> the outcome of its recent meeting the FDA aimed at clarifying a registration path for SM-88 in third-line pancreatic cancer.</li><li>The company will conduct a Phase 3 clinical trial with a primary endpoint of overall survival, a higher bar that does not bode well for success considering <a href=\"https://seekingalpha.com/news/3424226-tyme-48-percent-smminus-88-data\" target=\"_blank\">underwhelming mid-stage results</a>.</li><li>The company says that <a href=\"https://www.tymeinc.com/sm-88/what-is-sm-88/\" target=\"_blank\">SM-88</a> is a combination therapy that uses a proprietary dysfunctional tyrosine derivative to interrupt the metabolic processes of cancer cells, breaking down their defenses and making them vulnerable to oxidative stress and death.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436658\" data-linked=\"Tyme Tech down 6% on development path for SM-88 in pancreatic cancer\" data-tweet=\"$TYME - Tyme Tech down 6% on development path for SM-88 in pancreatic cancer https://seekingalpha.com/news/3436658-tyme-tech-down-6-on-development-path-for-smminus-88-in-pancreatic-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3436658-tyme-tech-down-6-on-development-path-for-smminus-88-in-pancreatic-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436649\" data-ts=\"1551115488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATEC\" target=\"_blank\">ATEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436649-fda-clears-alphatecs-safeop-system-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA clears Alphatec&#39;s SafeOp system; shares up 6%</a></h4><ul><li>Thinly traded nano cap Alphatec Holdings (<a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color=\"green\">+5.5%</font>) is up on more than a 17x surge in volume following the FDA's 510(k) <a href=\"https://seekingalpha.com/pr/17422744-alphatec-announces-fda-clearance-automated-safeop-neuromonitoring-system-address-significant\" target=\"_blank\">clearance </a>of its SafeOp neuromonitoring system used for the real-time monitoring of nerve location and health assessment during surgery.</li><li>Commercial launch will commence this Spring.</li><li>The company acquired the technology via its acquisition of SafeOp Surgical about a year ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436649\" data-linked=\"FDA clears Alphatec&#39;s SafeOp system; shares up 6%\" data-tweet=\"$ATEC - FDA clears Alphatec&#39;s SafeOp system; shares up 6% https://seekingalpha.com/news/3436649-fda-clears-alphatecs-safeop-system-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3436649-fda-clears-alphatecs-safeop-system-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436644\" data-ts=\"1551115357\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436644-semis-gain-on-trade-optimism\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Semis gain on trade optimism</a></h4><ul><li>The Philadelphia Semiconductor Index <font color=\"green\">gains 1.5%</font> compared to the <font color=\"green\">+0.6%</font> for the S&amp;P 500 after President Trump delays the US-China trade deal deadline. Many chip companies are also attending the Mobile World Congress this week.</li><li>On the move: (<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>+2.5%</font>), (<a href='https://seekingalpha.com/symbol/NXPI' title='NXP Semiconductors'>NXPI</a> <font color='green'>+3.2%</font>), (<a href='https://seekingalpha.com/symbol/CREE' title='Cree, Inc.'>CREE</a> <font color='green'>+2.7%</font>), (<a href='https://seekingalpha.com/symbol/TER' title='Teradyne Inc.'>TER</a> <font color='green'>+2.5%</font>), (<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='green'>+1.6%</font>), (<a href='https://seekingalpha.com/symbol/XLNX' title='Xilinx, Inc.'>XLNX</a> <font color='green'>+1.8%</font>), (<a href='https://seekingalpha.com/symbol/QRVO' title='Qorvo, Inc'>QRVO</a> <font color='green'>+1.5%</font>).</li><li>Related semiconductor ETFs: <a href='https://seekingalpha.com/symbol/SOXL' title='Direxion Daily Semiconductor 3x Bull Shares ETF'>SOXL</a>, <a href='https://seekingalpha.com/symbol/SOXX' title='iShares PHLX SOX Semiconductor Sector Index ETF'>SOXX</a>, <a href='https://seekingalpha.com/symbol/SMH' title='VanEck Vectors Semiconductor ETF'>SMH</a>, <a href='https://seekingalpha.com/symbol/USD' title='ProShares Ultra Semiconductors ETF'>USD</a>, <a href='https://seekingalpha.com/symbol/PSI' title='Invesco Dynamic Semiconductors Portfolio ETF'>PSI</a>, <a href='https://seekingalpha.com/symbol/XSD' title='SPDR S&P Semiconductor ETF'>XSD</a>, <a href='https://seekingalpha.com/symbol/SOXS' title='Direxion Daily Semiconductor 3x Bear Shares ETF'>SOXS</a>, <a href='https://seekingalpha.com/symbol/SSG' title='ProShares UltraShort Semiconductors ETF'>SSG</a>, <a href='https://seekingalpha.com/symbol/FTXL' title='First Trust Nasdaq Semiconductor ETF'>FTXL</a>, <a href='https://seekingalpha.com/symbol/XTH' title='SPDR S&P Technology Hardware ETF'>XTH</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436644\" data-linked=\"Semis gain on trade optimism\" data-tweet=\"$AMD $NXPI $CREE - Semis gain on trade optimism https://seekingalpha.com/news/3436644-semis-gain-on-trade-optimism?source=tweet\" data-url=\"https://seekingalpha.com/news/3436644-semis-gain-on-trade-optimism\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436636\" data-ts=\"1551114841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHFS\" target=\"_blank\">CHFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436636-chf-solutions-files-for-upsized-equity-offering-shares-down-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CHF Solutions files for upsized equity offering; shares down 2%</a></h4><ul><li>CHF Solutions (<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a> <font color=\"red\">-1.7%</font>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1506492/000114036119003726/s002610x5_s1a.htm\" target=\"_blank\">preliminary prospectus</a> for a $10.4M offering of Class A and Class B Units.</li><li>Specifically, the company will offer 202,247 Class A Units (price undetermined), each consisting of one common share, one five-year warrant to purchase one common share and another warrant to purchase one common share, and 808,988 Class B Units, each consisting of one share of Series G Convertible Preferred Stock, one Series 1 warrant and one Series 2 warrant, at an assumed price of $8.90, the closing price of its common stock on February 22.</li><li>The company <a href=\"https://seekingalpha.com/news/3424593-chf-solutions-files-equity-offering\" target=\"_blank\">filed </a>for a $5M equity offering a month ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436636\" data-linked=\"CHF Solutions files for upsized equity offering; shares down 2%\" data-tweet=\"$CHFS - CHF Solutions files for upsized equity offering; shares down 2% https://seekingalpha.com/news/3436636-chf-solutions-files-for-upsized-equity-offering-shares-down-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3436636-chf-solutions-files-for-upsized-equity-offering-shares-down-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436634\" data-ts=\"1551114075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436634-carters-and-nio-among-consumer-gainers-watt-leads-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carter&#39;s and NIO among consumer gainers; WATT leads the losers</a></h4><ul><li><b>Gainers: </b>Planet Green Holdings (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLAG' title='Planet Green Holdings Corp'>PLAG</a>) <font color=\"green\">+20%</font>. Libbey (NYSEMKT:<a href='https://seekingalpha.com/symbol/LBY' title='Libbey Inc.'>LBY</a>) <font color=\"green\">+13%</font>. Fuwei Films (NASDAQ:<a href='https://seekingalpha.com/symbol/FFHL' title='Fuwei Films &#40;Holdings&#41; Co., Ltd.'>FFHL</a>) <font color=\"green\">+10%</font>. Carter's (NYSE:<a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a>) <font color=\"green\">+10%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Energous (NASDAQ:<a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a>) <font color=\"red\">-8%</font>. Dorman Products (NASDAQ:<a href='https://seekingalpha.com/symbol/DORM' title='Dorman Products, Inc.'>DORM</a>) <font color=\"red\">-7%</font>. Reed's (NYSEMKT:<a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436634\" data-linked=\"Carter&#39;s and NIO among consumer gainers; WATT leads the losers\" data-tweet=\"$PLAG $LBY $FFHL - Carter&#39;s and NIO among consumer gainers; WATT leads the losers https://seekingalpha.com/news/3436634-carters-and-nio-among-consumer-gainers-watt-leads-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3436634-carters-and-nio-among-consumer-gainers-watt-leads-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436628\" data-ts=\"1551112972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436628-kids-clothing-names-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kids clothing names rally</a></h4><ul> <li>The Children's Place (NASDAQ:<a href='https://seekingalpha.com/symbol/PLCE' title='The Children&#39;s Place Retail Stores, Inc.'>PLCE</a>) <font color=\"green\">rallies 4.40%</font> after Carter's (<a href='https://seekingalpha.com/symbol/CRI' title='Carter&#39;s, Inc.'>CRI</a> <font color='green'>+10.6%</font>) delivers a strong earnings report.</li> <li>Carter's delivered its best holiday quarter comp since 2013 as double-digit e-commerce growth kicked in nicely.</li> <li>Carter's also released social media engagement statistics in its <a href=\"https://seekingalpha.com/article/4243806-carters-inc-2018-q4-results-earnings-call-slides#\" target=\"_blank\">earnings slides</a>, showing strong followings for both Carter's and Children's Place in comparison to some rivals.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436436-carters-beats-0_28-beats-revenue\" target=\"_blank\">Carter's beats by $0.28, beats on revenue</a> (Feb. 25)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436444-carters-q4-beat\" target=\"_blank\">More on Carter's Q4 beat</a> (Feb. 25)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436628\" data-linked=\"Kids clothing names rally\" data-tweet=\"$PLCE $CRI - Kids clothing names rally https://seekingalpha.com/news/3436628-kids-clothing-names-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3436628-kids-clothing-names-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:42 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436627\" data-ts=\"1551112698\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLAN\" target=\"_blank\">PLAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436627-anaplan-up-17-on-q4-results-beats-provides-fy20-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anaplan up 17% on Q4 results beats; provides FY20 guidance</a></h4><ul><li>Anaplan (<a href='https://seekingalpha.com/symbol/PLAN' title='Anaplan, Inc.'>PLAN</a> <font color=\"green\">+17.8%</font>) reported Q4 revenue growth of 49.5% Y/Y to $69.3M, with Subscription revenue of $59.7M (+44% Y/Y).</li><li>Q4 Billings were up by 54% Y/Y to $101.3M,</li><li>Q4 Gross margin <font color=\"green\">declined by 202 bps</font> to 70.9%; reported operating loss of $32.7M and margin -47.2% <font color=\"red\">down 452 bps</font>; and adj. operating loss of $15.9M and margin -22.7% <font color=\"green\">recovered by 1,276 bps</font>.</li><li>Net cash used in operating activities YTD was $45.85M, compared to $14.5M a year ago.</li><li>Free cash flow of negative $19.55M for the quarter.</li><li>Company has cash and cash equivalents of $326.86M, as of January 31, 2019.</li><li><strong>1Q20 Guidance:</strong> Revenue $70M-$71M; and adj. operating margin negative 34.5-35.5%.</li><li><strong>FY20 Guidance: </strong>Revenue $310M-$314M; and adj. operating margin negative 26-17%.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436474-anaplan-beats-0_05-beats-revenue\" target=\"_blank\">Anaplan beats by $0.05, beats on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436627\" data-linked=\"Anaplan up 17% on Q4 results beats; provides FY20 guidance\" data-tweet=\"$PLAN - Anaplan up 17% on Q4 results beats; provides FY20 guidance https://seekingalpha.com/news/3436627-anaplan-up-17-on-q4-results-beats-provides-fy20-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3436627-anaplan-up-17-on-q4-results-beats-provides-fy20-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436626\" data-ts=\"1551112563\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436626-windstreamminus-25-on-reports-of-bankruptcy-prep-unitminus-5_3-updated-new-halt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Windstream -25% on reports of bankruptcy prep; UNIT -5.3% (updated with new halt)</a></h4><ul>   <li>Windstream (NASDAQ:<a href='https://seekingalpha.com/symbol/WIN' title='Windstream Holdings, Inc.'>WIN</a>) has slammed into negative ground, <font color=\"red\">down 25.7%</font>, on Bloomberg headlines that it's preparing for a bankruptcy filing.</li>    <li>That filing would follow closely on the <a href=\"https://seekingalpha.com/news/3434156-windstream-minus-29-percent-loses-court-fight-aurelius\" target=\"_blank\">devastating loss to Aurelius Capital</a> in Windstream's debt-default trial.</li><li>The filing could come as soon as this week, according to Bloomberg.</li><li>Uniti Group (NASDAQ:<a href='https://seekingalpha.com/symbol/UNIT' title='Uniti Group Inc.'>UNIT</a>), briefly halted for volume, is <font color=\"red\">down 5.3%</font>. Uniti is linked to Windstream through a key master lease.</li><li><strong>Updated 11:45 a.m.:</strong> Windstream is now halted for news pending, <font color=\"red\">down 23.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436626\" data-linked=\"Windstream -25% on reports of bankruptcy prep; UNIT -5.3% (updated with new halt)\" data-tweet=\"$WINMQ $UNIT - Windstream -25% on reports of bankruptcy prep; UNIT -5.3% (updated with new halt) https://seekingalpha.com/news/3436626-windstreamminus-25-on-reports-of-bankruptcy-prep-unitminus-5_3-updated-new-halt?source=tweet\" data-url=\"https://seekingalpha.com/news/3436626-windstreamminus-25-on-reports-of-bankruptcy-prep-unitminus-5_3-updated-new-halt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>156&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436624\" data-ts=\"1551112430\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGTA\" target=\"_blank\">MGTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436624-magenta-up-7-on-cell-therapy-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magenta up 7% on cell therapy data</a></h4><ul><li>Thinly traded micro cap Magenta Therapeutics (<a href='https://seekingalpha.com/symbol/MGTA' title='Magenta Therapeutics'>MGTA</a> <font color=\"green\">+6.6%</font>) is up on below-average volume on the heels of <a href=\"https://seekingalpha.com/pr/17422533-magenta-therapeutics-presents-clinical-preclinical-data-mgtaminus-456-cell-therapy-best\" target=\"_blank\">new data</a> on cell therapy candidate MGTA-456. The results were presented at the Transplant and Cellular Therapy Annual Meeting in Houston, TX.</li><li>In a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03406962?lead=magenta&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 study</a>, 83% (n=5/6) of evaluable subjects with inherited metabolic disorders who received MGTA-456, designed to deliver a high dose of hematopoietic stem cells that are customized to the patient, met the primary endpoint of successful engraftment by day 42. The patients experienced minimal neutropenia (low blood platelets) lasting a median of one day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436624\" data-linked=\"Magenta up 7% on cell therapy data\" data-tweet=\"$MGTA - Magenta up 7% on cell therapy data https://seekingalpha.com/news/3436624-magenta-up-7-on-cell-therapy-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3436624-magenta-up-7-on-cell-therapy-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436616\" data-ts=\"1551111335\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORTX\" target=\"_blank\">ORTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436616-orchard-therapeutics-up-12-on-positive-otlminus-102-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orchard Therapeutics up 12% on positive OTL-102 data</a></h4><ul><li>Thinly traded Orchard Therapeutics (<a href='https://seekingalpha.com/symbol/ORTX' title='Orchard Therapeutics'>ORTX</a> <font color=\"green\">+12.2%</font>) is up on double normal volume, albeit on turnover of only 121K shares, in reaction to new <a href=\"https://seekingalpha.com/pr/17422350-orchard-therapeutics-presents-clinical-proof-concept-data-otlminus-102-treatment-x-cgd\" target=\"_blank\">proof-of-concept data</a> on gene therapy OTL-102 in patients with X-linked chronic granulomatous disease (X-CGD), a rare inherited disorder characterized by repeated chronic infections due to the inability of neutrophils (type of white blood cell) to kill pathogens. The results were first presented at ASH in December 2018.</li><li>86% (n=6/7) of treated patients showed more than 10% (range: 16 - 46%) functioning oxidase-positive neutrophils at month 12 (10% is the minimum threshold to demonstrate potential clinical benefit). The six subjects also showed stable vector copy number in neutrophils at month 12 which correlates to the engraftment of long-term repopulating hematopoietic stem cells.</li><li>On the safety front, there was one treatment-related serious adverse event, immune reconstitution inflammatory syndrome, which was resolved with steroids.</li><li><a href=\"https://seekingalpha.com/news/3436443-roche-acquire-spark-therapeutics-114_50-per-share\" target=\"_blank\">Roche's bid</a> for gene therapy developer Spark Therapeutics is also contributing to the spike in buying.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436616\" data-linked=\"Orchard Therapeutics up 12% on positive OTL-102 data\" data-tweet=\"$ORTX - Orchard Therapeutics up 12% on positive OTL-102 data https://seekingalpha.com/news/3436616-orchard-therapeutics-up-12-on-positive-otlminus-102-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3436616-orchard-therapeutics-up-12-on-positive-otlminus-102-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436609\" data-ts=\"1551110554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436609-spark-therapeutics-leads-healthcare-gainers-achieve-life-sciences-and-cronos-group-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spark Therapeutics leads healthcare gainers; Achieve Life Sciences and Cronos Group among losers</a></h4><ul><li><b>Gainers: </b>Spark Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a>) <font color=\"green\">+120%</font>. Clementia Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CMTA' title='Clementia Pharmaceuticals'>CMTA</a>) <font color=\"green\">+74%</font>. Titan Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a>) <font color=\"green\">+45%</font>. uniQure (NASDAQ:<a href='https://seekingalpha.com/symbol/QURE' title='uniQure N.V.'>QURE</a>) <font color=\"green\">+31%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical'>OASM</a>) <font color=\"green\">+20%</font>.</li><li><b>Losers: </b>Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <font color=\"red\">-22%</font>. OncoCyte (NYSEMKT:<a href='https://seekingalpha.com/symbol/OCX' title='OncoCyte Corporation'>OCX</a>) <font color=\"red\">-9%</font>. Melinta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNT' title='Melinta Therapeutics'>MLNT</a>) <font color=\"red\">-7%</font>. Cronos Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a>) <font color=\"red\">-6%</font>. Trinity Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIB' title='Trinity Biotech PLC'>TRIB</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436609\" data-linked=\"Spark Therapeutics leads healthcare gainers; Achieve Life Sciences and Cronos Group among losers\" data-tweet=\"$ONCE $CMTA $TTNP - Spark Therapeutics leads healthcare gainers; Achieve Life Sciences and Cronos Group among losers https://seekingalpha.com/news/3436609-spark-therapeutics-leads-healthcare-gainers-achieve-life-sciences-and-cronos-group-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3436609-spark-therapeutics-leads-healthcare-gainers-achieve-life-sciences-and-cronos-group-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436607\" data-ts=\"1551110394\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMAX\" target=\"_blank\">IMAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436607-canaccord-genuity-downgrades-imax-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord Genuity downgrades IMAX ahead of earnings</a></h4><ul> <li>Canaccord Genuity turns cautious in IMAX (NYSE:<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a>) a day ahead of the company's earnings report, moving to a Hold rating from Buy.</li> <li>\"With another very soft result out of China, we believe the market will continue to factor in a moderated China outlook with respect to the stock. Interestingly, we did see a very encouraging period of strength in the China box office during the Chinese New Year led by the local language titles, The Wandering Earth, Crazy Alien and Pegasus, with total box office of US$32.3-million over the period commencing on February 5. This is up 40 per cent over 2018. Nonetheless, given the recent trends, we believe that it would take a few quarters of out-performance in box office in China to change sentiment. Looking at the slate we continue to believe that $600k in PSA is likely the realistic base for China,\" warns the firm.</li> <li>Also working against IMAX is the high mix of studio tentpoles this year in the family genre (Dragon: The Hidden World, Dumbo, Toy Story 4, Lion King, and Frozen 2).</li><li>Shares of IMAX are <font color=\"red\">down 2.35%</font> in midmorning trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436607\" data-linked=\"Canaccord Genuity downgrades IMAX ahead of earnings\" data-tweet=\"$IMAX $IMXCF $IXCNY - Canaccord Genuity downgrades IMAX ahead of earnings https://seekingalpha.com/news/3436607-canaccord-genuity-downgrades-imax-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3436607-canaccord-genuity-downgrades-imax-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436604\" data-ts=\"1551110193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXK\" target=\"_blank\">EXK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436604-endeavour-silverplus-5-on-smaller-expected-loss-optimism-2019\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endeavour Silver +5% on smaller than expected loss, optimism about 2019</a></h4><ul><li>Endeavour Silver (<a href='https://seekingalpha.com/symbol/EXK' title='Endeavour Silver Corp.'>EXK</a> <font color=\"green\">+5.6%</font>) shoots higher after reporting a lighter than expected <a href=\"https://seekingalpha.com/news/3436445-endeavour-silver-beats-0_03-beats-revenue\" target=\"_blank\">Q4 loss</a> to conclude what it calls a \"transition year.\"</li><li>EXK says Q4 silver production fell 4% Y/Y to 1.38M oz. with all-in sustaining costs rising 12% to $14.20/oz. silver payable, as its realized silver price slid 12% to $14.88/oz. sold but rose 2% vs. the quarter's average spot price.</li><li>The Mexico-focused miner says it expects improved performance at the Guanacevi and Bolanitos miner during 2019 and to deliver its first year of commercial production at El Compas and beginning development of its fifth mine at Terronera upon receiving a positive board decision.</li><li><a href=\"https://seekingalpha.com/article/4243788-endeavour-silver-corp-2018-q4-results-earnings-call-slides\" target=\"_blank\">Presentation slides</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3436604\" data-linked=\"Endeavour Silver +5% on smaller than expected loss, optimism about 2019\" data-tweet=\"$EXK - Endeavour Silver +5% on smaller than expected loss, optimism about 2019 https://seekingalpha.com/news/3436604-endeavour-silverplus-5-on-smaller-expected-loss-optimism-2019?source=tweet\" data-url=\"https://seekingalpha.com/news/3436604-endeavour-silverplus-5-on-smaller-expected-loss-optimism-2019\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436601\" data-ts=\"1551109718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STAR\" target=\"_blank\">STAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436601-istar-drops-3_2-after-142m-impairment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">iStar drops 3.2% after $142M impairment</a></h4><ul><li>iStar (NYSE:<a href='https://seekingalpha.com/symbol/STAR' title='iStar Inc.'>STAR</a>) <font color=\"red\">slides 3.2%</font> after taking a<a href=\"https://seekingalpha.com/pr/17422275-istar-reports-fourth-quarter-fiscal-year-2018-results\" target=\"_blank\"> $142M impairment </a>in Q4.</li><li>Decided not to move forward with the development of some legacy assets.</li><li>Will continue to monetize legacy assets with the target of reducing legacy portfolio to less than 15% of its portfolio value over the next year.</li><li>Aims to combine iStar's strength in finance and net lease with Safehold's (<a href='https://seekingalpha.com/symbol/SAFE' title='Safety, Income and Growth Inc.'>SAFE</a> <font color=\"red\">-0.2%</font>) success at reinventing group leases; iStar is now SAFE's largest shareholder, after its additional $250M investment in January.</li><li>iStar Q4 adjusted EPS of 53 cents beats average analyst estimate of 31 cents; compares with 40 cents a year ago.</li><li>GAAP loss per share of $1.70 misses consensus by $1.64.</li><li><a href=\"http://ir.istar.com/phoenix.zhtml?c=96452&amp;p=quarterlyEarnings&amp;_ga=2.94754972.1050428348.1551108465-1876725323.1551108465\" target=\"_blank\">Q4 presentation</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436453-istar-beats-0_22-misses-revenue\" target=\"_blank\">iStar beats by $0.22, misses on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436601\" data-linked=\"iStar drops 3.2% after $142M impairment\" data-tweet=\"$STAR $SAFE - iStar drops 3.2% after $142M impairment https://seekingalpha.com/news/3436601-istar-drops-3_2-after-142m-impairment?source=tweet\" data-url=\"https://seekingalpha.com/news/3436601-istar-drops-3_2-after-142m-impairment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436600\" data-ts=\"1551109684\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AWI\" target=\"_blank\">AWI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436600-armstrong-world-industriesplus-3-post-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Armstrong World Industries +3% post Q4 results</a></h4><ul><li>Armstrong World Industries (<a href='https://seekingalpha.com/symbol/AWI' title='Armstrong World Industries, Inc.'>AWI</a> <font color=\"green\">+3.4%</font>) reported Q4 revenue growth of 11.4% Y/Y to $238.8M, driven by higher volumes in the Architectural Specialties segment, as well as higher Mineral Fiber average unit values.</li><li>Mineral Fiber segment sales $191.3M (+7.3% Y/Y); operating margin 25.5% <font color=\"green\">up 260 bps</font>; and Adj. EBITDA margin 37.1% <font color=\"green\">up 333 bps</font>.</li><li>Architectural Specialties sales $47.6M (+29.3% Y/Y); operating margin 12.8% <font color=\"red\">down 648 bps</font>; Adj. EBITDA margin 16.8% <font color=\"red\">down 493 bps</font>.</li><li>Q4 Gross margin <font color=\"green\">improved by 587 bps</font> to 34.4%; and operating margin <font color=\"green\">improved by 173 bps</font> to 22%.</li><li>Adj. EBITDA was $79M (+16.1% Y/Y) and margin<font color=\"green\"> improved by 135 bps</font> to 33.1%.</li><li>SG&amp;A expenses were $45.3M (+38.1% Y/Y) and margin 18.9% <font color=\"red\">up by 366 bps</font>.</li><li>Net cash provided by operating activities was $203.4M, compared to $170.4M a year ago. Adjusted free cash flow was at $62M (+18.8% Y/Y).</li><li><strong>FY19 Guidance:</strong> Adj. EBITDA $390M-$410M; Adj. EPS $4.30-$4.60; and Adj. FCF $220M-$240M. Company projects high-single digit sales growth fueled by volume gains in Architectural Specialties, AUV expansion in Mineral Fiber and acquisitions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3435408-armstrong-world-declares-0_175-dividend\" target=\"_blank\">Armstrong World declares $0.175 dividend</a> (Feb. 21)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436428-armstrong-world-misses-0_03-misses-revenue\" target=\"_blank\">Armstrong World misses by $0.03, misses on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436600\" data-linked=\"Armstrong World Industries +3% post Q4 results\" data-tweet=\"$AWI - Armstrong World Industries +3% post Q4 results https://seekingalpha.com/news/3436600-armstrong-world-industriesplus-3-post-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3436600-armstrong-world-industriesplus-3-post-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436598\" data-ts=\"1551109418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436598-cellectar-bio-up-7-on-positive-clr-131-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio up 7% on positive CLR 131 data</a></h4><ul><li>Thinly traded nano cap Cellectar Biosciences (<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color=\"green\">+7.2%</font>) is up on more than a 7x surge in volume, albeit on turnover of only 424K shares, in response to <a href=\"https://seekingalpha.com/pr/17422579-cellectar-reports-positive-top-line-response-rate-30-percent-r-r-multiple-myeloma-cohort\" target=\"_blank\">new data</a> from a Phase 2 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02952508?lead=cellectar&amp;phase=1&amp;rank=1\" target=\"_blank\">CLOVER-1</a>, evaluating lead candidate CLR 131 in patients with treatment-resistant B-cell blood cancers.</li><li>In the relapsed/refractory multiple myeloma cohort, the overall response rate was 30% (n=3/10) in the first 10 evaluable patients after a single infusion of CLR 131. All experienced stable cancer implying a 100% disease control rate.</li><li>The estimated primary completion date is December.</li><li>The company plans to launch Phase 1 studies assessing CLR 131 in pediatric patients with solid tumors and lymphoma and in combination with external beam radiation in patients with head and neck cancer.</li><li>CLR 131 is a phospholipid ether-drug conjugate &#40;PDC&#41; that selectively delivers radiation to malignant cancer cells.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436598\" data-linked=\"Cellectar Bio up 7% on positive CLR 131 data\" data-tweet=\"$CLRB - Cellectar Bio up 7% on positive CLR 131 data https://seekingalpha.com/news/3436598-cellectar-bio-up-7-on-positive-clr-131-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3436598-cellectar-bio-up-7-on-positive-clr-131-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436592\" data-ts=\"1551108726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRS\" target=\"_blank\">VLRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436592-deutsch-bank-upgrade-gives-lift-to-volaris\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsch Bank upgrade gives lift to Volaris</a></h4><ul> <li>Volaris Aviation (NYSE:<a href='https://seekingalpha.com/symbol/VLRS' title='Volaris Aviation'>VLRS</a>) <font color=\"green\">jumps 5.55%</font> after Deutsche Bank upgrades the airline stock to Buy from Hold.</li> <li>The investment firm assigns a price target of $12 to Volaris, compared to the old PT of $6.50 and 52-week high of $9.16.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3436592\" data-linked=\"Deutsch Bank upgrade gives lift to Volaris\" data-tweet=\"$VLRS - Deutsch Bank upgrade gives lift to Volaris https://seekingalpha.com/news/3436592-deutsch-bank-upgrade-gives-lift-to-volaris?source=tweet\" data-url=\"https://seekingalpha.com/news/3436592-deutsch-bank-upgrade-gives-lift-to-volaris\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436588\" data-ts=\"1551108396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESALY\" target=\"_blank\">ESALY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436588-eisai-files-for-revised-labeling-for-obesity-med-belviq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eisai files for revised labeling for obesity med Belviq</a></h4><ul><li>FDA accepts Eisai's (<a href='https://seekingalpha.com/symbol/ESALY' title='Eisai Co., Ltd. ADR'>OTCPK:ESALY</a> <font color=\"green\">+1.2%</font>) supplemental marketing application seeking approval to add long-term efficacy and safety data from the 12,000-subject Phase 4 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02019264?titles=camellia&amp;lead=eisai&amp;rank=1\" target=\"_blank\">CAMELLIA-TIMI 61</a> study evaluating the cardiovascular benefits of obesity med BELVIQ (lorcaserin HCl).</li><li>The results, <a href=\"https://seekingalpha.com/news/3370658-eisais-belviq-demonstrates-favorable-safety-profile-large-scale-cv-outcomes-study\" target=\"_blank\">reported </a>and published in the New England Journal of Medicine in August 2018, showed that long-term treatment with BELVIQ did not increase the incidence of major adverse cardiovascular events &#40;MACE&#41; in high-risk overweight and obese patients. It also showed its non-inferiority (no worse than) to placebo in terms of a MACE+ composite (CV death, non-fatal heart attack or stroke, hospitalization due to unstable angina, heart failure or coronary revascularization).</li><li>The company says the inclusion of the data in the labeling will enable the removal of Limitation of Use related to the effect of the drug on cardiovascular morbidity and mortality.</li></ul><div class=\"tiny-share-widget\" data-id=\"3436588\" data-linked=\"Eisai files for revised labeling for obesity med Belviq\" data-tweet=\"$ESALY $ESALF - Eisai files for revised labeling for obesity med Belviq https://seekingalpha.com/news/3436588-eisai-files-for-revised-labeling-for-obesity-med-belviq?source=tweet\" data-url=\"https://seekingalpha.com/news/3436588-eisai-files-for-revised-labeling-for-obesity-med-belviq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436589\" data-ts=\"1551108346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSA\" target=\"_blank\">NSA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436589-national-storageminus-1_7-after-q4-revenue-misses\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">National Storage -1.7% after Q4 revenue misses</a></h4><ul><li>National Storage Affiliates (NYSE:<a href='https://seekingalpha.com/symbol/NSA' title='National Storage Affiliates Trust'>NSA</a>) <font color=\"red\">falls 1.7%</font> after <a href=\"https://seekingalpha.com/pr/17422331-national-storage-affiliates-trust-reports-2018-fourth-quarter-full-year-results\" target=\"_blank\">Q4 revenue</a> of $89.3M falls short of the consensus estimate of $91.1M.</li><li>Q4 revenue rose 22% from $73.4M a year ago.</li><li>Q4 core FFO of 37 cents per share, beating consensus of 35 cents, and up from 32 cents a year ago.</li><li>Q4 same-store NOI growth of 5.3%; NOI margin of 68.9% improved from 68.2% a year ago.</li><li>Q4 average occupancy of 88.4% declined from 88.9% a year earlier.</li><li>2019 guidance: Core FFO per share and unit of $1.48-$1.52 compares with consensus estimate of $1.48.</li></ul><ol><li>Same-store total revenue growth of 2.5%-3.5%</li><li>Same-store NOI growth of 2.5%-3.5%.</li></ol><ul><li>After Q4-end, National Storage acquired 23 self-storage properties in six states for about $147M and agreed to add Moove In Self Storage of York, PA, as NSA's 10th PRO.</li></ul><ol><li>Moove In intends to contribute six self storage properties to NSA as part of the initial contribution transaction, and Moove In's remaining properties will be added to NSA's captive pipeline.</li></ol><ul><li><a href=\"https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.nationalstorageaffiliates.com&amp;esheet=51945128&amp;newsitemid=20190225005495&amp;lan=en-US&amp;anchor=www.nationalstorageaffiliates.com&amp;index=2&amp;md5=b0b2dd2f65b965fe44e000c2f2abe9a4\" target=\"_blank\">Conference call</a> at 1:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436481-national-storage-affiliates-beats-0_02-misses-revenue\" target=\"_blank\">National Storage Affiliates beats by $0.02, misses on revenue</a> (Feb. 25)</li></ul><div class=\"tiny-share-widget\" data-id=\"3436589\" data-linked=\"National Storage -1.7% after Q4 revenue misses\" data-tweet=\"$NSA - National Storage -1.7% after Q4 revenue misses https://seekingalpha.com/news/3436589-national-storageminus-1_7-after-q4-revenue-misses?source=tweet\" data-url=\"https://seekingalpha.com/news/3436589-national-storageminus-1_7-after-q4-revenue-misses\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436587\" data-ts=\"1551108171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCIX\" target=\"_blank\">DCIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436587-diana-containershipsminus-4-after-revenue-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diana Containerships -4% after revenue drop</a></h4><ul> <li>Diana Containerships (NASDAQ:<a href='https://seekingalpha.com/symbol/DCIX' title='Diana Containerships Inc.'>DCIX</a>) <font color=\"red\">falls 4.0%</font> after reporting a net loss of $400K for <a href=\"https://seekingalpha.com/pr/17422787-diana-containerships-inc-reports-financial-results-fourth-quarter-year-ended-december-31-2018\" target=\"_blank\">Q4</a>.</li> <li>Revenue fell 22% during the quarter primarily due to the decrease in the company's fleet size. Time charter rates were higher as a result of improved market conditions.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436548-diana-containerships-reports-q4-results\" target=\"_blank\">Diana Containerships reports Q4 results</a> (Feb. 25)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3436587\" data-linked=\"Diana Containerships -4% after revenue drop\" data-tweet=\"$DCIX - Diana Containerships -4% after revenue drop https://seekingalpha.com/news/3436587-diana-containershipsminus-4-after-revenue-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3436587-diana-containershipsminus-4-after-revenue-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436585\" data-ts=\"1551108055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436585-inseego-teaming-ericsson-on-5g-nr-deployment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inseego teaming with Ericsson on 5G NR deployment</a></h4><ul>   <li>Inseego (NASDAQ:<a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a>) is <font color=\"green\">up 1.3%</font> this morning after a spate of Mobile World Congress announcements includes news that it's been <a href=\"https://seekingalpha.com/pr/17422499-ericsson-inseego-partner-make-5g-nr-networks-real\" target=\"_blank\">chosen by Ericsson</a> (<a href=\"http://seekingalpha.com/symbol/ERIC\" target=\"_blank\">ERIC</a> <font color=\"red\">-2.5%</font>) to help bring 5G New Radio solutions to market.</li>    <li>The company's 4G LTE and 5G NR solutions are supportive of the latest 3GPP specifications.</li>    <li>Inseego's patented (and recently rebranded) MiFiiQ enhancements include new antenna designs, quick response algorithms for 5G use cases and stronger security.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436585\" data-linked=\"Inseego teaming with Ericsson on 5G NR deployment\" data-tweet=\"$INSG $ERIC - Inseego teaming with Ericsson on 5G NR deployment https://seekingalpha.com/news/3436585-inseego-teaming-ericsson-on-5g-nr-deployment?source=tweet\" data-url=\"https://seekingalpha.com/news/3436585-inseego-teaming-ericsson-on-5g-nr-deployment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436584\" data-ts=\"1551107818\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436584-gm-and-ford-expected-to-gain-u-s-market-share-in-february\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GM and Ford expected to gain U.S. market share in February</a></h4><ul> <li>Bank of America Merrill Lynch expects U.S. auto sales to fall 1% in February to a seasonally adjusted annualized rate of 16.8M.</li> <li>The firm anticipates that Ford (<a href='https://seekingalpha.com/symbol/F' title='Ford Motor Company'>F</a> <font color='green'>+0.9%</font>) and General Motors (<a href='https://seekingalpha.com/symbol/GM' title='General Motors Company'>GM</a> <font color='green'>+0.8%</font>) will outperform during the month amid relative weakness from European and Japanese brands. Ford's U.S. sales are forecast to be up 2.5% Y/Y and GM's sales are seen rising 5%.</li> <li>The BAML team is still somewhat cautious on the sector as it looks ahead.</li> <li>\"As we head into 2019, a few emerging risks are becoming increasingly concerning to us, including potential used vehicle pricing pressure (from rising supply), rising interest rates, and now the risk of delayed and/or muted tax refunds due to the government shutdown, as well as changes (or lack thereof) in withholdings following tax reform in 2018,\" warn analyst John Murphy and team.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436584\" data-linked=\"GM and Ford expected to gain U.S. market share in February\" data-tweet=\"$F $GM - GM and Ford expected to gain U.S. market share in February https://seekingalpha.com/news/3436584-gm-and-ford-expected-to-gain-u-s-market-share-in-february?source=tweet\" data-url=\"https://seekingalpha.com/news/3436584-gm-and-ford-expected-to-gain-u-s-market-share-in-february\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>75&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436583\" data-ts=\"1551107493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VEON\" target=\"_blank\">VEON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436583-veonplus-2_7-on-q4-revenue-strength-raised-dividend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veon +2.7% on Q4 revenue strength, raised dividend</a></h4><ul>   <li>Veon (NASDAQ:<a href='https://seekingalpha.com/symbol/VEON' title='VEON Ltd. ADS'>VEON</a>) is <font color=\"green\">up 2.7%</font> after its Q4 revenues came in ahead of consensus and the company approved a final dividend boost of about 3.6%.</li>    <li>Total revenue fell as reported, but rose 5.3% on an organic basis, led by strength in Russia, Pakistan and Ukraine.</li>    <li>EBITDA grew 10% on an organic basis, thanks to operational strength in Pakistan and Ukraine.</li>    <li>Revenues were hit by foreign-exchange effects, with currency headwinds of $285M hitting overall revenue of $2.25B, and $111M hitting EBITDA of $714M.</li>    <li>It's guiding to 2019 organic revenue growth in the low single digits, with organic EBITDA growth inthe low to mid-single digits.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436417-veon-beats-revenue\" target=\"_blank\">VEON beats on revenue</a> (Feb. 25 2019)</li>    <li><a href=\"https://seekingalpha.com/pr/17422015-veon-reports-good-full-year-2018-results\" target=\"_blank\">Press release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3436583\" data-linked=\"Veon +2.7% on Q4 revenue strength, raised dividend\" data-tweet=\"$VEON - Veon +2.7% on Q4 revenue strength, raised dividend https://seekingalpha.com/news/3436583-veonplus-2_7-on-q4-revenue-strength-raised-dividend?source=tweet\" data-url=\"https://seekingalpha.com/news/3436583-veonplus-2_7-on-q4-revenue-strength-raised-dividend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3436577\" data-ts=\"1551107215\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3436577-nioplus-8-after-60-minutes-spotlight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nio +8% after 60 Minutes spotlight</a></h4><ul> <li>Nio (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a>) <font color=\"green\">rallies 8.20%</font> in morning trading after the company's high-profile exposure on 60 Minutes last night.</li> <li>Shares of Nio are now up 38% YTD.</li> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is <font color=\"green\">up 2.63%</font> following the 60 Minutes segment on the broad Chinese EV market, while Kandi Technologies (<a href='https://seekingalpha.com/symbol/KNDI' title='Kandi Technologies Group, Inc.'>KNDI</a> <font color='red'>-4.9%</font>) has cooled off a bit. Analysts say the biggest takeaway from the CBS profile on the Chinese EV market is that while model competition is rapidly heating up, new entrants will need to prove themselves on quality and driving range.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3436405-chinese-ev-market-profiled-60-minutes\" target=\"_blank\">Chinese EV market profiled on 60 Minutes</a> (Feb. 24)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3436577\" data-linked=\"Nio +8% after 60 Minutes spotlight\" data-tweet=\"$NIO $TSLA $KNDI - Nio +8% after 60 Minutes spotlight https://seekingalpha.com/news/3436577-nioplus-8-after-60-minutes-spotlight?source=tweet\" data-url=\"https://seekingalpha.com/news/3436577-nioplus-8-after-60-minutes-spotlight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>66&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}